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iABSTRACT
The status of radiotherapy as an important treatment modality for cancer is
indisputable. In external beam radiotherapy, usually delivered with linear accel-
erators (linacs), there is a total uncertainty involved in the treatment process, in
which the accuracy of the dose calculation is a significant factor. In patient dose
calculation, the radiation beam produced by the linac is modelled and delivered
to the calculation phantom, which is based on computed tomography (CT)
datasets. Most of the clinical dose calculation algorithms implemented in
treatment planning systems (TPSs) have been based on analytical or semi-ana-
lytical principles, but statistical Monte Carlo (MC) methods have been shown to
provide the most accurate representation of dose distributions in the patient and
other calculation phantoms. However, long calculation times have prohibited
the implementation of full MC methods to clinical patient dose calculation.
In this study, the aim was to develop a full MC-based dose calculation tool to
serve as a reference method for TPS dose calculation algorithm benchmarking,
but also for dosimetry purposes. The MC-based model constructed for both
photon and electron beams was first benchmarked against measurements in
water. Finally, the value of the absolute dose calibrated MC model was assessed
by applying it to specific problems in dosimetry and dose calculations.
The performance of the MC model in this study in a water phantom was shown
to be equal or better than that reported in other studies. During the stage in
which the multileaf collimator (MLC) part of the MC model was benchmarked,
the MC-based results were used to assess the performance of various
measurement detectors in small aperture dosimetry. Eventually, the MC model
was shown to provide reference dose distributions both in virtual and CT-based
phantom geometries, where accurate measurements are difficult or impossible
to perform. With photon beams, the MC model was used to benchmark the TPS
algorithms in cases where large uncertainties have been reported, i.e. in the
stereotactic body radiotherapy (SBRT) of the lung and in the presence of high
atomic number material as a metallic hip implant. With electron beams, the MC
model was applied to assess the accuracy of the TPS algorithms in chest wall
radiotherapy.
With the described use, in addition to performed TPS configuration data
validation, the MC model has the potential to have a positive influence on the
total uncertainty involved in radiotherapy. Furthermore, the MC model can be
used in the development of new treatment techniques, protocols and detectors
for dosimetry and dose calculation algorithms. The time when full MC-based
calculations are implemented into clinical treatment planning is yet to come.
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11. INTRODUCTION
Radiotherapy is one of the three most often used treatment modalities for
patients diagnosed with cancer and it is usually combined with surgery and/or
chemotherapy. [1] Chemotherapy acts systemically to treat the disease in all
affected parts of the body, while surgery and radiotherapy aim for local control.
The radiobiological effect of radiotherapy is based on the ability of the ionising
radiation to harm the malignant cells so that their reproduction is inhibited and
cell death follows during the course of treatment and thereafter. Ideally, only
the malignant cells would be killed and healthy cells would be preserved, but
unfortunately, due to the non-selective and stochastic nature of radiation energy
absorption at the cellular level, normal tissue is also affected. This leads to the
objective of radiotherapy that is to deliver the prescribed amount of radiation
(absorbed dose) at the target volume to be treated and minimise the dose
elsewhere in the body, especially in organs-at-risk (OARs). The therapeutic
gain is optimised when the dose at the target volume is maximised for a given
normal tissue dose ([2]).
External radiotherapy treatment can be divided into different phases, such as
imaging for treatment planning, treatment planning and treatment, and each of
them involves uncertainty that affects the treatment outcome. There are also
various factors, not linked to the patient treatment workflow itself, but to
inherent performance and calibration/configuration accuracy of treatment
machines and computer software that have a direct impact on the accuracy of
the treatment delivery. Most of these factors are related to dosimetric properties
of the treatment machine output and to the performance of dose calculation
algorithms of the treatment planning system (TPS). In the report by the
American Association of Physicists in Medicine (AAPM) Task Group No. 105
(TG-105) ([2]) and in [3] it was summarised that, for example, dose differences
in the order of 7% are shown to cause clinically detectable changes in treatment
outcomes ([4]) and dose differences of 5% may result in substantial changes in
tumour control probability (TCP) and normal tissue complication probability
(NTCP) ([5-7]). The report by AAPM TG-65 ([8]) presented the effects of
various sources of uncertainty in the treatment procedure on the total
uncertainty involved in the treatment at present and the anticipated levels in the
future. In Table 1 it can be seen that while the uncertainties related to the
2absolute calibrated dose and dose calculation have had a major impact on the
total uncertainty to date, correspondingly the improvements sought in the future
are predicted to decrease the total uncertainty levels drastically. However, to
benchmark and monitor the related accuracy levels, more advanced methods
and tools for quality assurance (QA) are required.
Table 1. Estimates of uncertainty (in terms of one standard deviation) in absolute dose
in the patient for the complete treatment procedure using megavoltage photons, today
and in the future. (‘Present’ refers to the year 2004) [8]
The majority of radiotherapy treatments are delivered with a linear accelerator
(linac). In Figure 1 a typical medical linac is visualised and certain parts
described below are numbered. Modern linacs are isocentric in construction,
which means that all the parts of the linac rotate about a certain point in space,
the isocentre. The gantry of the linac rotates ±180º from an upright position
about a horizontal axis (dashed line in Figure 1) and the treatment couch and
collimator rotation axes intersect on the horizontal axis at the isocentre. The
electrons are produced by an electron gun (1) and they are accelerated in a
linear standing or travelling wave accelerator guide (2). After a bending magnet
system (3) the electrons enter a linac treatment head and impinge on a high-
density X-ray target (4), in which a bremsstrahlung photon beam is generated.
The beam is collimated to a desired size and shape with: 1) a primary collimator
(5), which is located below the X-ray target and has a conical opening, 2) a
secondary collimator (9), which consists of two pairs of high-density blocks
(‘jaws’) that move in crossplane (X) and inplane (Y) directions, when viewing
from a beam’s eye view (BEV), and 3) a computer-controlled multileaf
collimator (MLC) (10) below the jaws, which typically consists of 40 to 60
pairs of thin opposing individual leaves that move in a crossplane direction. In
the beam path there is also a thin vacuum exit window, a beam flattening filter
(6) to flatten the photon beam that is more intense around the beam central axis
3(CAX), a dual transmission ionisation chamber (IC) (8) for beam monitoring, a
field light mirror, a light field reticle and a plastic sheet. With the electron beam
the X-ray target is retracted and the flattening filter is replaced by a scattering
foil system (7). The jaws are in a preset static position, the MLC is retracted
and the beam is directed towards the patient using an electron applicator
attached to the bottom of the treatment head and shaped with an electron cutout
positioned to the bottom of the applicator. [1]
Figure 1. A visualisation of a clinical linac (Varian Clinac iX, Varian Medical Systems
Inc., Palo Alto, CA, USA). The numbered items are described in the text. (Image
courtesy of Varian Medical Systems)
Dosimetric measurements comprise a significant part of essential procedures in
linac commissioning and during the operation. The linac has to be calibrated in
terms of beam output and other beam properties prior to clinical use, and these
parameters are to be monitored following a QA programme. The stability and
accuracy of these basic parameters have a direct connection to the overall total
uncertainty of the treatment process, as seen in Table 1. In addition to
advancements in dosimetric methods, which have improved and are expected to
improve the involved uncertainty levels affecting the treatment procedures, also
modern treatment techniques have been developed, which introduce new
4dosimetric challenges. While point and one-dimensional (1D) profile
measurements have sufficed in the past, the demand for two-dimensional (2D)
planar and three-dimensional (3D) volumetric measurements has increased
along with intensity-modulated radiotherapy (IMRT) and volumetric modulated
arc therapy (VMAT). These treatment techniques, in combination with sharp
dose gradients and small field apertures, have added complexity to dosimetry.
Apart from these issues, if more accurate patient treatment delivery is sought,
QA procedures related to various treatment techniques and TPS dose
calculation software benefit from dose measurements in heterogeneous
phantoms that mimic patient anatomy and composition. However, the more
realistic and complex phantom, e.g. anthropomorphic phantom, is desired, the
more challenging it is to produce accurate, high-resolution, multidimensional
measured dose distributions. The above-mentioned issues are discussed and
further information on various tools and techniques for IMRT can be found in
the report from the AAPM TG-120 ([9]).
In dose calculation, the absorbed dose in the calculation volume is determined
by modelling the dose deposition by the transport of photons and electrons,
with their interactions, in matter. In the past the dose calculations were based on
various corrections to patient heterogeneity, distance variations and surface
irregularities applied to measured dose distributions in water phantom. The
introduction of computed tomography (CT) to radiotherapy enabled the
contouring of treatment volumes and OARs and the dose calculation based on
electron density calculation grid acquired from the patient CT dataset. In
modern model-based dose calculation methods, the treatment beam is modelled
as a multiple source model and the measurement data is used to fine-tune the
model to represent the output of the linac. The dose deposition in the patient is
calculated by applying superposition and convolution principles in combination
with heterogeneity correction methods. [10] The most recent generation of
commercial dose calculation algorithms is based on ‘fast’ implementations of
statistical Monte Carlo (MC) methods or grid-based linear Boltzmann transport
equation (LBTE) solver. [2,11] What is common for all the commercial dose
calculation algorithms is that they need to be extensively benchmarked prior to
clinical use and both phantom and patient verification against other independent
dose determination methods, such as measurements, have to be performed
following the QA programme. As the reported accuracy of the algorithms has
improved, it has introduced challenges for dosimetric methods, as described
above. The only means to compare the full dose distribution calculated by a
commercial algorithm in a patient CT dataset is to compare it to the results of
another dose calculation method.
5The use of MC methods in radiotherapy originates from the 1970s. Their
various applications have included the design of treatment head components,
the determination of reference data for dosimetry, and the production of
reference dose distributions for TPS QA. [12] Nowadays ‘full’ MC simulations
are considered the gold standard for calculating dose distributions for
radiotherapy purposes ([12]), especially in complex-shaped heterogeneous
geometries ([2]). However, prior to utilising the full MC simulations for
reference purposes, the MC models have to be commissioned and benchmarked
with caution. Appropriately configured, they can be used for various purposes
in radiotherapy QA, as long as sufficient computational resources are available,
since it is an inherent characteristic of MC methods that statistical uncertainty
of the resulting dose distributions decreases when the number of statistically
sampled and simulated events is increased, which in turn increases the
calculation time. [12] The MC methods have been extensively used in the
literature and more information on their history, theory and applications can be
found in extensive review articles, e.g. [12-16].
62. AIMS OF THE STUDY
The general objective of this work was to develop a full MC-based dose
calculation tool, mainly to be used as a reference method for TPS dose
calculation algorithm commissioning and QA procedures, but also to establish a
reference for dosimetry purposes. The aim was to configure and benchmark the
MC-based model for both photon and electron beams, calibrate it for absolute
dose calculation, and implement the option to simulate dose distributions in CT-
based phantoms. Finally, the value of the MC model was assessed by applying
it to specific problems in radiotherapy dosimetry and dose calculations.
The specific aims of the study were as follows.
1. To construct MC models, which would represent the photon and electron
beams of a selected treatment unit and show as small deviations from the
well-defined measurements as possible;
2. To construct an MLC model within the photon beam MC models that would
show as small deviations from the measurements as possible, which is
essential for accurate IMRT and VMAT dose calculations;
3. To use the MC model for the accuracy assessment in the following areas of
application:
 a new TPS photon beam dose calculation algorithm in comparison to
two other TPS algorithms in the stereotactic body radiotherapy (SBRT)
of the lung, which uses small field apertures;
 a new TPS photon beam dose calculation algorithm in the presence of
high-density implanted material in comparison to measurements in a
phantom and to other TPS algorithm in a patient case example, in which
a hybrid VMAT technique is applied;
 two TPS electron  beam dose calculation algorithms in chest wall radio-
therapy, with reference to the dose to lung and mediastinum;
4. To use the MC model to provide the first evaluation of the accuracy of a new
TPS photon beam dose calculation algorithm in VMAT dose calculation in
comparison with full MC simulations.
73. BACKGROUND
The MC methods, which are applied to numerical integrations by means of
random sampling and statistics, are in general well-suited for modelling particle
transport in physics. The transport of photons and electrons in a medium with
their random trajectories is simulated using probability distributions
representing the likelihood of individual interactions. Each particle induces a
cascade of interactions, and the physical quantities of interest are recorded on
the course. The track of one particle is called a particle history and the result is
an average of a large number of particle histories. In other words, since these
methods are of a stochastic nature, it can be summarised that when using the
MC techniques, random numbers are sampled from a user-defined input domain
and they are used to perform a large number of separate output simulations. The
results are combined and analysed and a simplified result is to fall within
evaluated statistical uncertainty limits. In radiation transport calculations, the
accuracy of cross-section data for individual interactions, which represents the
likelihood of the interactions, has a fundamental relevance in the overall
accuracy of the MC simulation results. [2,13,17]
3.1. BEAMnrc Monte Carlo simulation system
The MC simulations in this study are performed with a BEAMnrc code system
([18]). The history of the system and underlying codes dates back to the 1970s,
but the versions from 2007, 2009, 2010 and most recently, from 2013 were
applied. The system is owned and maintained by the National Research Council
(NRC) of Canada. The BEAMnrc system is built around EGSnrc (electron
gamma shower) general purpose code, simulating the photon and electron
interactions and transport in medium ([19]). BEAMnrc is a general purpose
EGSnrc user code for simulating radiation sources and the option to model
radiation transport through a linear accelerator treatment head was applied in
this study ([20]). DOSXYZnrc is a general purpose EGSnrc user code to score
an absorbed dose in a rectilinear voxelised phantom geometry ([21]). Another
user code, ctcreate, allows the user to build a DOSXYZnrc phantom from a CT
dataset, in which the dose is then calculated ([21]). PEGS4 is a data preparation
code part of the EGSnrc that can be utilised to determine cross-section data for
user-defined materials ([19]).
83.1.1. Radiation transport physics modelling (EGSnrc)
3.1.1.1 Photon interactions
Photon transport in a BEAMnrc system is governed by modelling four different
types of interactions: 1) coherent (Rayleigh) scattering, 2) photoelectric
absorption, 3) incoherent (Compton) scattering, and 4) pair production. A
photon interaction process, where photons are scattered by bound atomic
electrons, without exciting or ionising the atom, is called coherent scattering. In
this process, no energy is transferred to charged particles – the incident photon
is scattered to account for the small recoil energy. Coherent scattering is
characteristic of low energy photons traversing in high atomic number (high-Z)
material (in this study, ‘high-Z’ refers to materials of higher (effective) atomic
number and density than that found in human tissues). [17] In EGSnrc, the
default total coherent scattering cross-sections are based on the work by Storm
and Israel ([19,22]) and atomic form factors on the work by Hubbel and Øverbø
([19,23]), but other options for cross-section data are also available. It is
recommended that the Rayleigh scattering option is turned on for calculations,
in which particle energies are of the order 1 MeV and less. [19]
In photoelectric absorption the whole energy of the incident photon is absorbed
by a tightly-bound orbital electron of the atom. This electron, a photoelectron,
is ejected with a kinetic energy equal to the energy of the original photon, from
which the binding energy of the electron is subtracted. If the resulting energy is
large enough, the photoelectron is emitted from the atom and the atom is
ionised, but when the energy is below this level, the photoelectron rises to a
higher orbit and the atom is excited. If the photoelectron is emitted, the vacancy
is filled by an electron from a higher shell and the energy difference between
the orbital energy levels is emitted as a fluorescent (characteristic) X-ray photon
or as an Auger or Coster-Kronig electron. [17] In EGSnrc, the default total
photo-absorption cross-sections are based on the work by Storm and Israel
([19,22]) and the direction sampling on the Sauter distribution ([19,24]), but
other options for cross-section data are also available. The cross-section for the
photoelectric effect is considerably larger than for the coherent scattering in the
low energy range (~1 MeV) ([17]).
In the case of incoherent (Compton) scattering, the incident photon interacts
with a loosely bound orbital electron. As a result, the photon is scattered and its
energy is smaller than the energy of the incident photon. The energy difference
is transferred as kinetic energy to the orbital electron, which is ejected from the
atom. The formalism to determine the cross-section for the interaction is based
on the work by Klein and Nishina, and the work by Hubbell at the National
Institute for Science and Technology (NIST) in the United States
9complemented the theory to account for the electron binding energy effects that
are especially noticeable at low photon energies in high-Z materials. [17] In
EGSnrc, the incoherent scattering calculations were originally based on Klein-
Nishina theory, but in most recent versions of the code system, the option to
utilise the binding effects and Doppler broadening following the impulse
approximation principle has also been included. [19] Incoherent scattering is the
predominant photon interaction type at photon beam energies typically used in
radiotherapy.
At photon energies greater than 1.022 MeV, pair production is possible. In this
interaction type, the photon is absorbed with all its energy in the atom nuclear
field and an electron-positron pair is formed. When the photon interacts with an
orbital electron with energies exceeding 2.044 MeV, a triplet production may
occur, when in addition to electron-positron pair production, an electron is also
ejected. [17] In EGSnrc, the pair production cross-section data is based on
extreme relativistic first Born approximation, described in work by Motz, Olsen
and Koch ([19,25]). This cross-section data is improved by introducing an
empirical correction factor based on the work by Storm and Israel ([19,22]). In
the most recent version of the code system, the cross-section data is further
enhanced to account for corrections based on the partial-wave analysis
calculations by Øverbø, Mork and Olsen ([19,26]). The triplet production in
EGSnrc is explicitly simulated following the first Born approximation theory
reported by Votruba ([19,27]) and Mork ([19,28]).
3.1.1.2 Electron interactions
The number of electron interactions along a certain traversed path length in
medium is much greater than for the same path length with photons, because
the electrons have electric charge and non-zero rest mass. There are two types
of basic interactions through which the electrons lose energy, namely radiative
energy losses and inelastic collisions with atomic electrons. Radiative energy
losses occur via bremsstrahlung formation, which is a result of electrons and
positrons undergoing a Coulomb interaction with an atomic nucleus, and
positron annihilation, which is a result of positrons annihilating with orbital
electrons. As a result of positron annihilation, most commonly two annihilation
photons with energy of 0.511 MeV are created, moving in opposing directions.
When electrons undergo inelastic collision with orbital electrons, the energy
transfer may result in atomic ionisation or excitation. In addition to the above-
mentioned interaction types, the elastic collision of an electron, which occurs
with an atomic nucleus, is an interaction process that contributes to the angular
deflections of electrons, but not to energy transfer.
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Since the simulation of every individual electron interaction is impractical and
changes in the electron state due to single interaction are usually small, Berger
introduced a condensed history (CH) technique. It models a number of electron
interactions, leading to both energy and directional changes, in a single ‘step’
([19,29]). The choice of step-size is bipolar: 1) the step-size has to be so large
that sufficiently large number of interactions occur in order that the multiple
scattering theories are applicable, but 2) the step-size has to be small enough so
that the cumulative contributions to deflections in electron tracks and energy
losses are such that the simulation provides accurate results in terms of voxel-
based energy deposition, boundary crossings and electron-track generation. In
EGSnrc, the CH technique belongs to Class II scheme, which means that as a
result of ‘catastrophic’ collisions, where bremsstrahlung photons and atomic
electrons set in motion possess energies greater than set energy thresholds, the
resulting photons and electrons are simulated as individual particle tracks. The
particles with energies less than threshold levels are simulated by applying
continuous slowing-down approximation (CSDA). [19]
The EGSnrc bremsstrahlung production cross-section data for energy levels
applied in radiotherapy are based on first Born approximation Bethe-Heitler
data with an empirical correction factor. Other options are to use the NIST
bremsstrahlung cross-section data or further enhanced NIST data from the
NRC. [19] With electron-electron and positron-electron inelastic collisions, the
Moller ([19,30]) and the Bhabha ([19,31]) cross-section data is used,
respectively. When including the atomic electron binding, these interactions
may produce inner shell vacancy, which in EGSnrc is called electron impact
ionisation and when included in simulations, one of the empirically obtained
cross-section data can be selected. Two-photon positron-electron annihilation
processes are also simulated in EGSnrc. The cross-section data for elastic
collision of an electron that occurs with an atomic nucleus, which also takes
into account spin effects, is based on the partial-wave analysis solution of the
Dirac equation following the work by Mott ([19,32]). Finally, if the atom is in
an excited state after Compton and photoelectric processes, the atomic
relaxation to the ground state results in the emission of characteristic X-rays
and/or Auger or Coster-Kronig electrons. In EGSnrc, this is explicitly modelled
for shell vacancies with binding energies greater than 1 keV. [19]
With the EGSnrc CH technique, the path length, energy loss, change in
direction and spatial displacement for each step in the random walk are
determined using various approximate methods, since the exact solutions for
the equations including the parameters are not known. The implemented
electron-step algorithm produces accurate transport in an infinite, homogeneous
medium for varying step sizes. For electron transport in heterogeneous medium,
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a boundary crossing algorithm is also needed, since near a material interface the
curved path of an electron may cross a material boundary and then cross back to
the original material. Thus, the transport steps on the other side in different
material would be different from the ones in the original medium. In EGSnrc
this is overcome by changing the elastic scattering from multiple to single
mode, when the distance to the boundary is smaller than the set limit.
3.1.2. Source and geometry modelling (BEAMnrc)
BEAMnrc is a general purpose EGSnrc user code for simulating radiation
sources and modelling radiation transport through various structures, such as a
linac treatment head. In Figure 2 the simulation process is presented as a flow
chart. The simulation is based on the geometry model of the treatment head,
which has a modular layered structure. First, the user must specify which
separate parts are to be included and this is done with component modules
(CMs). There are a number of CMs for various structures and they are
completely independent, non-overlapping blocks in the geometry model. Then
the accelerator model is built and compiled, for which various input parameters
and cross-section data must be specified prior to simulation. In the input file the
user provides detailed information on the geometry and material specification
for each CM, specifies the desired output data form, defines parameters that
specify the transport physics modelling and cross-section data and lastly,
defines the radiation source. The source is located at the entry surface of the
first CM or certain types of sources may be located between CMs. [20]
Figure 2. A flow chart of the simulation using the BEAMnrc code system. [18]
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In a radiotherapy treatment simulation, the output data is usually collected on a
user-specified plane, to a phase space file, in which the energy, position,
direction, weight and charge of each particle is recorded. Options for various
output listings and output graphics files for treatment visualisation are also
available. The phase space file data can be used as input for BEAM Data
Processor (BEAMDP) utility for deriving particle energy spectral, mean energy,
planar fluence and angular distributions. The most general use for the phase
space file is to employ it as a plane source for the phantom simulation. [20]
3.1.2.1 Radiation sources in BEAMnrc code system
In addition to the option to use a phase space file as a source in the BEAMnrc
accelerator simulation (ISOURC = 21), there are 15 other source options in the
BEAMnrc code system version 2013. Most commonly, in the case of treatment
head simulation, the radiation source is the electron beam that is directed
downwards from the bending magnet system, right above the horizontal level of
the X-ray target. For this purpose there are two sources in the BEAMnrc code
system version 2013: ISOURC = 0, which is a parallel circular beam, and
ISOURC = 19, which an elliptical beam with Gaussian distribution profile in an
X and Y direction. In this study, ISOURC = 19 was applied to characterise the
initial electron beam in the simulations. The beam profile is defined either by
standard deviation or full width at half maximum (FWHM) in cm in both the X
and Y direction. The incident beam energy may be monoenergetic or the user
may define an energy spectrum. The user can select whether the beam is set
parallel to the incident beam axis or they can choose to apply a mean angular
spread about the beam CAX. [20] One of the subjects of most intense research
in linac beam modelling has been the selection of initial electron beam
parameters that produce the best congruence between the simulation results and
the measured reference dose distributions. The reason for this is that the linac
manufacturers have not provided detailed information on the initial electron
beam characteristics and the parameters are extremely difficult to determine
through measurements. Therefore, the most general option is to build a detailed
geometry model of the treatment head, select appropriate physics simulation
parameters, and perform an elaborate and laborious iterative tuning process for
each initial electron beam parameter.
3.1.2.2 Geometry modelling in BEAMnrc code system
The geometry model consists of CMs that are independent blocks that take up a
horizontal slab portion of the model, such as in the linac treatment head. In the
BEAMnrc code system version 2013 there are 25 different CMs, which are
designed to cover various purposes in the modelling of other types of radio-
therapy treatment machines, such as tomotherapy units. In this section only
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those CMs that are used in this study are described and their schematics are
shown in Figure 3 (a)-(b). [20]
SLABS is the most simplistic CM, which is used to model one or more slabs of
material. The materials and thicknesses of slabs in square outer boundaries may
vary and the structures are perpendicular to the axis that represents beam CAX.
CONS3R is a CM with a cylindrical structure that has an interior and outer
region, which can be different media. CONS3R is ideal for modelling conical
structures. The region boundary is defined as a series of successive points, as
seen in Figure 3 (a). FLATFILT is the most general purpose of the CMs that are
rotationally symmetric about the beam CAX. It can be used to simulate multiple
stacked cones. The number of cones on each level is arbitrary and the material
for each cone in each layer can be different. The most common use for
FLATFILT is the photon beam flattening filter modelling. CHAMBER is a
cylindrical CM specialised in parallel plate monitor IC modelling. [20]
For beam collimation there are several specific CMs. SYNCJAWS, which is
used in this study, is an improved version of DYNJAWS (which in turn is a
version of JAWS shown in Figure 3 (b)), which allows the dynamic motion of
structures either in ‘step-and-shoot’ or ‘dynamic’ mode. What is common to all
three CMs is that they can be used to model an arbitrary number of paired
blocks in two perpendicular horizontal orientations. Most commonly these CMs
are used to model two pairs of secondary collimators in a linac treatment head
in an X and Y direction. The option for ‘dynamic’ motion allows the simulation
of enhanced dynamic wedge (EDW) fields and the improvement in
SYNCJAWS is to enable the synchronised movement with several other CMs,
beam simulation and dose calculation with DOSXYZnrc. This is analogous to
DYNVMLC and SYNCVMLC, which can be used to model the Varian
Millennium (Varian Medical Systems Inc., Palo Alto, CA, USA) MLC. The
complex structure consists of three different types of leaves and their cross-
sections. The leave ends can be straight or round and the leave side surfaces can
be focused to a point above, in the treatment head. As with CMs modelling the
jaws, the leaves may either define a static field or the simulation may be in
‘step-and-shoot’ or in ‘dynamic’ mode. SYNCVMLC allows a synchronised
simulation similar to SYNCJAWS. [20,33] PYRAMIDS is a CM for modelling
rectangular collimators or blocks, which is implemented with pyramid-shaped
structures with an arbitrary number of layers. Each layer has three regions, all
of which may be assigned a different medium. In addition, there are certain
CMs, such as MIRROR and APPLICAT, which are designed for modelling
certain specific structures, but in this study these structures are modelled with
the more general purpose CMs mentioned above. [20]
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Figure 3. (a) Schematics of the CMs used in this study. [20]
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Figure 3. (b) Schematics of the CMs used in this study. [20]
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3.1.3. Dose calculation (DOSXYZnrc)
The actual dose calculation in the BEAMnrc code system is performed with
DOSXYZnrc, which is a general purpose EGSnrc user code. It is used to
simulate the electron and photon transport and score an absorbed dose in a
rectilinear voxelised phantom geometry. DOSXYZnrc is accompanied with
ctcreate, which is a user code that can be used to build a DOSXYZnrc phantom
from a CT dataset, in which the dose is then calculated. The user may also
define a virtual phantom of arbitrary size and the sizes of volume elements
(voxels) in the phantom may vary in all three dimensions. The voxels can be of
any density and/or material. The materials for the phantoms are defined in the
PEGS4 material library, which is a file that contains the cross-section data for
each material. ctcreate reads slices in the CT dataset and converts the
Hounsfield Unit (HU) values to material densities and assigns a material for
each voxel, according to a user-defined conversion curve. [21]
In DOSXYZnrc there are 12 different sources to be used in simulations. Many
of them are similar to radiation sources included in the BEAMnrc code system,
but most often the option to utilise a phase space file from a BEAMnrc
simulation or a full BEAMnrc treatment head simulation is used, as is this case
in this study. For these purposes there is isource = 2, which is the phase space
source with which the user may arbitrarily choose the direction of the source
plane and distance with regard to the phantom. This is visualised in Figure 4.
[21]
Figure 4. Visualisations of the DOSXYZnrc sources used in this study. [21]
isource = 20 is a source, where the same phase source is used from multiple
directions and between the phase space source plane and the phantom there is
an option to insert a part of treatment head components which may have
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different settings depending, on the position of the source plane in regard to the
phantom, for example. This allows the simulation of continuous motion of the
source, to which the synchronised movement of beam-modifying components,
such as jaws and MLC, simulated with SYNCJAWS and SYNVMLC CMs, is
linked. The simulation of these components is performed as a shared library,
which is dynamically loaded by DOSXYZnrc at run time. isource = 21 is
otherwise similar to isource = 20, but the phase space source is replaced with a
full BEAMnrc treatment head simulation (Figure 4). [21,33]
3.1.4. Variance reduction techniques in BEAMnrc system
The MC calculation efficiency, epsilon (İ), is defined as:
TsTNs
N
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where N represents the number of simulated particle histories, s2 represents an
estimate of the true variance (ı2) of the quantity of interest, such as absolute
dose, and T represents the total central processing unit (CPU) calculation time
needed to reach the variance. It can be shown that the efficiency is more or less
independent of N. If one aims to enhance the efficiency, either 1) T needs to be
decreased for a given N, keeping the s2 unchanged, or 2) s2 needs to be
decreased for a given T. A technique that improves the efficiency without
introducing significant bias to the result, by changing the s2 for  given  N,  is
called a variance reduction technique. This is not to be confused with such
efficiency enhancement methods where improved efficiency is achieved by
making deliberate approximations into radiation transport calculations. [2,34]
There are several variance reduction techniques implemented in the BEAMnrc
system. The most straightforward, which is rarely even considered as a variance
reduction technique, is to increase the electron energy cutoff values that define
the energies at which the electron particle history is terminated and the energy
is locally absorbed. A similar but more sophisticated method is the range
rejection technique. There are several options for performing the range
rejection, but the basic idea is to terminate the charged particle history and
deposit all the energy locally, if the energy of the particle is too small and thus
the range is too short to cross the region boundary or to reach the region of
interest. This introduces an approximation to the simulation, since by depositing
the charged particle energy via range rejection, the contribution to elsewhere
than current region by bremsstrahlung photons that would have been created
without range rejection is neglected. One aim in the design of the variance
reduction technique called photon forcing was to improve the production of
contaminant electrons in air in photon beam simulations. The parent photons
are forced to interact in user-specified CMs and in order to sustain an unbiased
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result, the weights of the unscattered and scattered photons were distributed
accordingly. [2,18,20]
Bremsstrahlung photon splitting techniques are often used in treatment head
simulations to enhance the simulation statistics of photons generated in electron
interactions. Instead of generating only one bremsstrahlung secondary photon in
such interaction, the photon is split into a large number of secondary photons,
adjusting the weights and survival of the photons accordingly to maintain
unbiased simulation results. In a BEAMnrc system there are three options for
bremsstrahlung splitting: uniform bremsstrahlung splitting (UBS), selective
bremsstrahlung splitting (SBS) and directional bremsstrahlung splitting (DBS).
The largest efficiency improvement has been shown by DBS, which has
similarities with SBS in applying the technique only to the photons that are
directed towards the field of interest downstream in the treatment head, in
companion with the Russian Roulette feature. [2,18,20,35]
The most recent addition to variance reduction techniques in the BEAMnrc
system is the bremsstrahlung cross-section enhancement (BCSE). BCSE is
designed to improve efficiency in simulations where bremsstrahlung targets are
utilised for X-ray beam production. This is done by artificially increasing the
number of statistically-independent photons generated in interactions resulting
in bremsstrahlung emission. The merit of BCSE is best seen in low energy
applications and the largest efficiency gain is achieved when it is used with
UBS or DBS. [20,36]
3.2. Reference measurement data acquisition for MC
model commissioning
The commissioning of a linac MC model intended for various TPS
benchmarking and QA purposes is an iterative multiphase process. As
described in Section 3.1.2., prior to simulation the geometry model and initial
electron beam parameters, among other input data, have to be determined. The
detailed geometric and material information on each component of the linac
treatment head usually needs to be requested from the linac manufacturer or
determined via mechanical or attenuation measurements. Another option is to
use phase space files available from public databases or the manufacturer.
However, depending on what part of the treatment head is modelled in these
ready-to-use files, using them is always a more limited option in terms of
matching and tuning the MC model to a certain linac, in comparison to
modelling the whole treatment head, including the initial electron beam.
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The first parameter set for the initial electron beam should follow the estimated
values from the manufacturer and/or the values used in other studies. To find
the optimal initial electron beam energy spectrum, an acceptable congruence, ‘a
match’, between the calculated and measured depth dose distribution should be
found. The criterion for a match is up to the user – e.g. according to [12] an
agreement is found if the local differences at depths greater than the depth of
dose maximum (dmax) are smaller than 2%. The depth dose measurements
should follow well-known protocols, such as the International Atomic Energy
Agency (IAEA) TRS-398 ([37]) or the report from the AAPM TG-51 ([38]), in
order to obtain reference level comparison data. For photon beams a medium-
sized field, e.g. 10 x 10 cm2, with a source-to-surface/skin distance (SSD) of
100 cm and a cylindrical, thimble IC with active volumes of order 0.1 cm3, with
effective point of measurement (EPOM) correction applied, represents a typical
measurement set-up.
After tuning the initial electron beam energy spectrum, the next step in the
iterative MC model tuning process is to choose whether the initial electron
beam is a pencil beam of a certain width (usually between 0-2 mm) or a beam
with Gaussian intensity distribution (usually 1-2 mm FWHM). By varying the
width of the beam, the calculated dose distributions are to be compared to
measured relative dose profiles of a large field size beam at slightly greater
depths than dmax. [12,39] The measurements should follow the above-mentioned
protocols and a good choice for the detector is a medium or small volume
cylindrical IC, with minimal directional dependence. In addition, if dose
distributions outside the field, e.g. in the shadow of collimators, are of interest,
the detector should not be oversensitive to scattered radiation. In the tuning
process, a match is found when the local differences in flat, high dose regions
of the dose profile are below the set criterion, e.g. 1-2%, and the distance-to-
agreement (DTA) at a 50% dose level (when the dose profile is normalised to
100% at beam CAX) would be as small as possible. When the latter criterion is
fulfilled, it suggests that the field size defined by the jaws with the MC model is
in agreement with the actual field defined by the jaws with the linac. To fine-
tune the MC model, a divergence of 0-1º to the initial electron beam could also
be applied. Since the parameters defining the initial electron beam, its width
and divergence have small combined influence on the depth dose distribution,
the original match with the measured depth dose has to be verified ([40]). In
case of worse agreement, all the steps need to be repeated until both depth dose
distributions and dose profiles agree with the measured dose distributions at the
desired agreement level. [12]
An agreement for one field size in depth dose distributions and for another field
size in dose profiles at one depth does not ascertain that the MC model would
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produce congruent dose distributions for the whole field size range at all depths.
[39,41] Regardless of the field size, for the dose in the dose build-up region it is
difficult to produce reference measurement data, due to large dose gradients and
charged particle disequilibrium, and thus special attention has to be paid to the
measurement equipment selection. The most common detectors for
measurements on the surface and build-up dose region include semiconductor
detectors, radiochromic films and parallel plate ICs with empirical correction
methods, for which the small dimension of the active volume in the direction of
the beam is common. [42-44] The challenges in the modelling of the dose
build-up region are pronounced, especially with the largest field sizes. The
issues are related to the performance of the MC model in simulating the extra-
focal radiation, i.e. the scattered photons and contamination electrons from the
treatment head components and air, when the collimators are wide open ([45-
46]). On the other hand, according to some studies, the small field sizes are
recommended for tuning the initial electron beam energy spectrum, since the
effect of the extra-focal component of the beam is less pronounced, and thus the
primary electron energy spectrum affects the depth dose distributions the most
([12,47-48]).
Small field dosimetry has become an area of intense research during the past
decade, since the advances in radiotherapy treatment techniques have favoured
the utilisation of small fields and field apertures. There are a number of related
theoretical and technical issues that pose serious challenges, if reference-level
measurement data for small field dose distributions is desired. [49-50] The
detector selection for the measurements should be performed with great care.
For the performance, high spatial resolution and water equivalence are primary
attributes ([51-53]). The former is also important if one wants to minimise the
averaging effect, which is related to the size of the detector active volume, in
field penumbrae (in the region of 80%-20% relative dose) in dose profiles for
all field sizes ([54]). No ideal detector has yet been found especially for small
field dosimetry, but, e.g. semiconductor and diamond detectors, radiochromic
films and liquid-filled ICs, among others have shown good characteristics, but
all of them have suffered from some drawbacks [55-56]. It has even been
hypothesised that instead of attempting to design an ideal detector or
determining correction factors ([57]) via, MC calculations ([58-59]), for
example, the dosimetric quantities could be directly calculated, which would be
equivalent to performing measurements in ideal conditions ([50]). Many aspects
of and challenges related to small field dosimetry have been comprehensively
discussed in the Institute of Physics and Engineering in Medicine’s (IPEM)
Report Number 103 ([60]).
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For electron beams the initial electron beam tuning process is similar to photon
beams. For reference depth dose measurements with electron beams Roos or
NACP-type well-guarded parallel plate ICs are recommended detector choices
with an SSD of 100 cm and a 20 x 20 cm2 field defined by the electron
applicator, according to well-known dosimetry protocols, such as IAEA TRS-
398 ([37]) and AAPM TG-51 ([38]). With dose profile measurements, medium
or small volume cylindrical ICs are recommended. If a high resolution is
desired, for example in dose profile penumbrae or in depth dose distributions at
depths smaller than dmax, unshielded semiconductor and diamond detectors and
radiochromic films are preferable choices ([61-63]). In output factor
measurements it is similar for both photon and electron beam dosimetry that the
detector sensitivity should be large enough for stable readings and the radiation
fluence across the detector active volume should be uniform. Both issues bring
about challenges, especially with small fields, where output factors are usually
measured with semiconductor or diamond detectors. [37,60] If multiple
detectors are utilised in output factor measurements, it is recommended to
perform measurements with overlapping field sizes and apply the ‘daisy-
chaining’ technique to combine the results ([64]). In this work, the
measurement depths for output factors were 5 and 10 cm for 6 MV and 18 MV
photon beams, respectively, and dmax for electron beams.
What is common for both photon and electron beam dosimetry when acquiring
reference dose distributions for the commissioning of an MC model is that the
assets of each dosimetry technique and device should always be taken into
account. There is no ideal detector for the whole field size range and for all
purposes. Therefore, in an ideal case, the reference dose distributions should be
combined results from measurements with multiple detectors and measurement
techniques.
3.3. Treatment beam simulations and dose distribution
calculations applying MC methods
3.3.1. Photon beams
With time, the MC models have begun to produce dose distributions with
comparable accuracy to measurements in square fields and they have been
introduced as alternative reference methods to various applications in dose
calculations and dosimetry. As the MC codes and computing resources have
evolved, the MC codes have become the gold standard method for simulating
dose distributions in heterogeneous phantom and patient geometries ([2,12]).
However, all the studies applying MC methods agreed that the MC model
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requires rigorous and comprehensive commissioning, including benchmarking
in well-known conditions, before it can be utilised as a reference for other
purposes.
Studies which describe the MC model commissioning and tuning process and
the resulting performance in water phantom compared to measurements are
numerous. The early works focused on the quantification of various beam
properties, such as scatter components ([65-66]), energy and angular
distributions ([67-68]), dosimetric quantities ([69]), and the contribution from
different treatment head components ([70]). Many groups studied the effect of
different simulation parameters to calculated dose distributions and attempted
to achieve as good congruence with the reference percentage depth dose (PDD)
curve, dose profile and output factor measurements as possible. They also
discussed the possible reasons for deviations. It was common that with field
sizes from 2 x 2 cm2 to 40 x 40 cm2 in PDDs at depths beyond dmax, dose
profiles in high dose regions and output factors agreements better than ±1-2%
of dose at dmax (Dmax), ±2-3% of Dmax and ±1-2%, respectively, were attained.
[40-41,46,71-79] However, in the build-up region in PDDs, especially with
large fields and high nominal beam energies, large discrepancies were reported
with linacs in clinical use. To explain the discrepancies, potential sources and
solutions, such as: 1) lack of neutron simulation ([80]), 2) insufficient electron
contamination modelling ([45,48]), 3) utilisation of improved dosimetry
techniques for collecting comparison data ([81-82]), 4) improved transport
physics modelling ([81,83]), and 5) more detailed knowledge on treatment head
geometry ([41,84]) were investigated. This was different from research linacs,
with which the details needed in simulations are well known and thus the
differences from empirically corrected measurements were less than ±1%
([85]).
The MLC is one of the most complex structures of the treatment head in regard
to geometry modelling and commissioning benchmarking, due to small,
complex details in the geometry and consequent challenges in the acquisition of
reference measurement data for comparison. There are reports on the modelling
and benchmarking of Elekta MLC (Elekta Oncology Systems, Crawley, UK)
([86-87]), BrainLAB m3 microMLC (BrainLAB, Feldkirchen, Germany) ([88-
90]), Varian MarkII, Millennium ([91-97]) and HD120 ([98-99]) MLC (Varian
Medical Systems Inc., Palo Alto, CA, USA). Benchmarking has included MLC-
shaped static and dynamic MLC fields in both ‘step-and-shoot’ and ‘dynamic’,
‘sliding window’ mode. The most detailed MC MLC models have resulted in
good agreement with static and dynamic field profile, transmission and 2D dose
distribution measurements, which in turn have resulted in the conclusion that
MC models are applicable to IMRT and VMAT dose calculation.
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3.3.2. Electron beams
The earliest studies using the first version of the BEAM code system mostly
concentrated on modelling the clinical electron beams. As with photon beams,
many investigations focused on the quantification of various dosimetric beam
properties, such as stopping-power ratios ([100-101]) and energy-related
parameters ([102]). In studies where the MC model simulation parameters were
tuned to obtain the best agreement with PDD, dose profile and output factor
measurements, it was not uncommon that the local differences of smaller than
±1-3% of Dmax in PDDs, ±1-2% of Dmax in dose profiles in high dose regions, 1-
2 mm in DTA in profile penumbrae and ±1-2% in output factors were obtained
for beams with nominal energies of between 4 MeV and 50 MeV ([18,103-
109]).
3.3.3. Heterogeneous phantoms and patient plan calculation
Once the accuracy of the simulated radiotherapy beam coming out of the
treatment head is satisfactory when compared to measurements, there are
several issues that have to be taken into account prior to heterogeneous
phantom or patient plan simulations. If the simulations are to be performed in
virtual phantoms, the construction of the rectilinear phantom geometry is
straightforward. In order to compare the simulations to measurements, the user
may for example define a whole or half slab or other arbitrary shape of non-
water-equivalent material and otherwise assign the phantom as water or water-
equivalent plastic phantom material. As an example, films between the slabs in
the phantom or other detectors in water can be used to collect the reference
measurement data for comparison. [2]
Whether the phantom is virtual or CT-based, has the correct material
assignment and in addition with CT-based phantoms, has a verified HU value to
material density conversion curve, are crucial elements for the achievement of
accurate MC-calculated dose distributions. [110-113] The conversion must be
extended to high HU values if the calculation phantoms include high-Z
materials. [114] If the MC model is intended for TPS dose calculation
benchmarking, the curve for MC simulations should be identical to that used in
the TPS. Prior to utilising the MC model for further purposes, the
commissioning should include tests with heterogeneous phantoms, for which
reference measurements are available. The heterogeneities should include low
and high-density tissue-equivalent and high-Z material inserts of varying sizes.
The materials should represent lung ([115-118]) and bone tissues ([119]), also
applicable for electron beam treatments ([120-121]), and high-Z metals or metal
alloys ([122]), so that the accuracy of the MC model would be tested under
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conditions of charged particle disequilibrium and at various material interfaces.
The benchmarking should also contain clinically more relevant anthropometric
phantoms, which geometrically represent anatomical regions, such as thorax or
pelvic phantoms, and anthropomorphic phantoms ([123-125]) which, in
addition to geometrical dimensions, are also made of tissue-equivalent
materials. [2]
An MC model that is appropriately commissioned can be used in TPS dose
calculation algorithm benchmarking with virtual phantoms or patient CT
datasets. The model can be applied to cases where commercial dose calculation
algorithms are known to produce inaccurate dose distributions or to cases where
no experience on the performance of the commercial algorithms is available. In
general, materials with densities and atomic compositions significantly
differing from water have been reported to cause large uncertainties in dose
calculation. The effects are especially pronounced in anatomical sites where
there are tissues with widely varying densities in complex 3D shapes. At the
other extreme end of the density range are airways, especially of interest in
head and neck radiotherapy, where large photon/electron energy fluence
perturbations are introduced into the air and in the vicinity of air/tissue
interfaces. Low-density materials, such as lung tissue, have probably elicited
the greatest level of interest among the radiotherapy community, since the
insufficient and/or imperfect inclusion of electron transport modelling has
caused substantial uncertainties – as large as around 10% to 20% ([2-3]) – in
clinical dose calculations, the greatest being with high energy photon beams
and with small fields, especially applied in the SBRT of the lung ([126]). At the
other end of the density range there are bone and high-Z materials used in
implants, such as titanium-based, iron-based and cobalt-based alloys, and alloys
used in dental implants. Since bone has a greater effective atomic number than
water-like tissues, the particle transport phenomena and thus the contribution to
dose distribution are different, and therefore the requirements for
inhomogeneity correction in dose calculation differ from those for other tissues.
The introduced uncertainties with non-biological high-Z materials have caused
other types of challenges than tissues of lower density. The dose perturbation
effect due to high-Z materials is usually considered to be so severe that it has
become common to avoid such beam directions where the beam would first
traverse the high-Z material, prior to impinging on the volume to be treated.
This has been the case with hip implants in particular, when radiotherapy has
been applied to the pelvic region. [2,8,122]
The particle transport phenomena and the absorbed dose deposition of electron
beams differ significantly from photon beams and thus the foundations of the
radiotherapy dose calculation are very distinct. The reason is that with electron
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beams the number of interaction events per unit path length is much greater and
therefore also the trajectory shapes are more complex. However, regardless of
this, it has been common with the photon beams that materials with densities
and atomic compositions significantly differing from water have also caused
large uncertainties in electron beam dose calculation. Since the electron beams
are usually applied to malignancies that are superficial on the skin or at shallow
depths, the main interests have been related to heterogeneities such as airways,
bone and lung tissue near the skin surface. Due to the physical properties of the
electron beam, the high-Z materials have usually been avoided between the
treatment beam and the volume to be treated, unless such materials are
intentionally used for shielding. Issues related to larger uncertainties in dose
calculation with electron beams have also included the consideration of small,
irregular fields, oblique incident fields, extended SSD fields and both electron-
electron and photon-electron treatment field junctions. [2,127]
Examples of applications utilising MC models in TPS benchmarking are found
with 3D conformal radiotherapy (3D-CRT) ([128]), IMRT ([129]), head and
neck IMRT and VMAT ([130-132]), prostate IMRT ([131]), total body
irradiation (TBI) ([133]), SBRT of the lung ([134]) and electron radiotherapy
([135]) plans. There are studies where MC-based patient plan simulation
systems are developed for all types of plan verification, including 3D-CRT
([136]), IMRT ([136-137]), electron radiotherapy ([136]), VMAT ([138-139])
and flattening filter free VMAT ([140]) techniques. The most developed MC-
based patient plan calculation systems for TPS benchmarking and plan
verification feature graphical user interfaces (GUIs) to ease the workflow with
photon ([141-144]) and electron ([145]) beam radiotherapy. In addition,
separate radiotherapy research software platforms are employed to allow the
dose distribution visualisation, analysis and other applications ([146-148]).
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4. THE MC MODELS FOR PHOTON AND
ELECTRON BEAMS – CONSTRUCTION
AND BENCHMARKING
The BEAMnrc code system was installed and run on the calculation grid of the
Tampere Center for Scientific Computing (TCSC) at Tampere University of
Technology (TUT) (Tampere, Finland) between 2009 and 2014. In the grid,
there were 200-400 cores, including computing nodes with dual-core and six-
core AMD (Advanced Micro Devices, Inc., Sunnyvale, CA, USA) Opteron
processors and quad-core Intel (Intel Corporation, Santa Clara, CA, USA) Xeon
processors.
The MC models were based on the Varian Clinac iX (Varian Medical Systems
Inc., Palo Alto, CA, USA) medical linac commissioned in 2007 at the Unit of
Radiotherapy, Department of Oncology, Tampere University Hospital (Tays)
(Tampere, Finland). The manufacturer provided the author with a confidential
proprietary information package (Monte Carlo Data Package: High Energy
Accelerator) in 2009, and an updated version of the package followed in 2011.
The package contains detailed information on the treatment head component
geometries and materials. The information incorporated in the package was
used in the MC models for the most part. However, geometrical details of
readily accessible treatment head components that were not included in the
package were measured. Those that were included were re-measured to ensure
the correctness of the information. The elimination of some obvious erratic or
conflicting information in the package was clarified by contacting the
manufacturer.
4.1. The geometry models for photon and electron
beams
In this study the MC models for photon beams of nominal energies 6/18 MV
and for electron beams of nominal energies 6/9/12/16 MeV were
commissioned. For 6 MV photon beam and 16 MeV electron beam the MC
model commissioning is partly presented in [I] and for 6/18 MV photon and
9/16 MeV electron beam models in [149]. The geometry model is aligned so
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that the Z-axis in the model is the beam CAX. The origin of the Z-axis (Z = 0
cm) is set to the upper, ‘front’ surface level of the X-ray target. The X- and Y-
axes are set to coincide with the linac coordinate system, that is, the X-axis
represents the crossplane direction and Y-axis denotes the inplane direction.
Table 2 lists the treatment head components included in the geometry models
and the corresponding CMs that were used to model the structures.
Table 2. The components included in the photon and electron beam geometry models
and the corresponding CMs used.
Component Photon beammodel
Electron beam
model
X-ray target*/vacuum** SLABS* SLABS**
Primary collimator CONS3R CONS3R
Vacuum exit window SLABS SLABS
Flattening filter*/scattering foil** FLATFILT* FLATFILT**
Dual monitor IC CHAMBER CHAMBER
Mirror and mirror frame with shielding FLATFILT FLATFILT
Secondary collimator (jaws) SYNCJAWS SYNCJAWS
MLC SYNCVMLC SYNCVMLC
Light field reticle plastic sheet SLABS SLABS
Interface mount PYRAMIDS PYRAMIDS
Electron applicator with square cutout - PYRAMIDS
X-ray target
The first component in the geometry model was the transmission type X-ray
target. It is usually made of a high-Z material, such as tungsten or copper
([10,12,150]) (manufacturer proprietary information). The layered structure of
the component was modelled with SLABS CM. Knowledge of correct layer
thicknesses and materials is essential in order to model realistic beams. Since
the width of the initial electron beam coming from the bending magnet system
is small compared to the realistic size of the X-ray target, the size of the
modelled structure is not important, that is, it can be considered a semi-infinite
slab. With an electron beam the X-ray target is retracted and the whole CM is
assigned as a vacuum.
Primary collimator
The fixed primary collimator, which is in vacuum, is modelled with CONS3R
CM. The collimator, which is made of high-Z material, such as tungsten or lead
(manufacturer proprietary information), has a conical opening directed
downstream, in the direction of the beam. It defines the maximum circular
beam, which is further collimated with the jaws and the MLC. As shown in
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[84], the radii of the beam entrance and exit openings of the primary collimator
strongly influence the beam properties, and therefore it is important to define
the correct beam opening angle, which is about 28º. The lateral thickness of the
structure has to be large enough for the shielding to be similar to a real linac.
Vacuum exit window
The last component in a vacuum, modelled with SLABS CM, is the thin
window at the bottom of the primary collimator. The requirement for the
window is to maintain a vacuum with minimal impact on the radiation beam.
Flattening filter
The fixed component that modulates the primary photon beam the most is the
flattening filter, which is modelled with FLATFILT CM. In the linac treatment
head it is located in the carousel, where all the flattening filters and electron
beam scattering foils are found. The main function of this conical structure is to
flatten the forward-peaked photon beam intensity so that the beam produces flat
dose distribution at a depth of 10 cm in water phantom at SSD 100 cm ([12]).
The geometry of this component is extremely detailed, with highly non-linearly
shaped surface, and it is usually made of some high- or medium-Z material, e.g.
lead, tungsten, steel or aluminium, or a combination of these ([10])
(manufacturer proprietary information). The coordinates and layer thicknesses
for the flattening filter geometry models were interpolated using the proprietary
information from the manufacturer. The position and shape of the filter are very
important, since any misalignment or incorrect shape will alter beam symmetry
and flatness. Figure 5 (a)-(b) shows the geometry models for the 6 MV and 18
MV flattening filter, respectively.
Figure 5. (a) A 6 MV flattening filter and (b) a 18 MV flattening filter geometry
models, respectively. Note the conical insert made of a second material inside the filter
in (b).
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Scattering foil
The electron beam scattering foil, modelled with FLATFILT CM, is used to
spread the narrow beam generating as small an amount of contaminant
bremsstrahlung radiation as possible. Typically it is a two-layer structure,
consisting of thin primary foil, which is made of high-Z material, such as lead
([150]) (manufacturer proprietary information), and which acts as a scatterer,
followed by a secondary foil of medium-Z material (manufacturer proprietary
information), which is slightly conical in shape, similar to X-ray flattening
filter, thus attempting to flatten the beam. The resulting electron beam
characteristics are highly sensitive to the thicknesses and materials of both
scattering foils and the mutual distance ([104]). They form a set of parameters
in combination with initial electron beam parameters that need to be optimised
in the MC model commissioning phase. Figure 6 shows a dual scattering foil of
a high energy electron beam.
Figure 6. A dual scattering foil of a
high energy electron beam.
Figure 7. A dual monitor IC.
Dual monitor IC
The monitor IC, which monitors various beam parameters, consists of two
stacked identical transmission parallel plate ICs in a 90º orientation relative to
each other. It has a complex structure, i.e. there are number of plastic sheets
with electrodes, in addition to protective cover sheets ensuring the sealing,
which all are separated by very small distances. In the outer wall there are two
annuli made of medium-Z material (manufacturer proprietary information). In
this study CHAMBER CM was used to model the structure shown in Figure 7.
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Mirror and mirror frame with shielding
In the BEAMnrc system there is a dedicated MIRROR CM for modelling the
field light mirror tilted to an angle relative to the beam CAX. However, this CM
does not allow the modelling of surrounding structures for the tilted mirror
structure. In [84] the discrepancies in the build-up dose between the MC model
and measurements with a high energy photon beam were studied. One of the
conclusions was that the underestimation of the build-up dose was due to
deficiencies in electron contamination modelling. A partial solution to this was
to include the complex-shaped lead shield around the mirror in the MC model,
which was implemented with a simplified conical structure with the mirror with
its frame as a horizontal annulus. The approach was also implemented in this
study (Figure 8) and therefore instead of MIRROR CM, FLATFILT CM was
used to model the structure. The beam opening angle, defined by the plastic
mirror sheet and its frame made of medium-Z material (manufacturer
proprietary information), was projected on a horizontal level, as were the
thicknesses of the corresponding structures. The opening angle of the
surrounding conical structure made of high-Z material (manufacturer
proprietary information) was matched to that of the primary collimator.
Figure 8. The mirror (a), mirror frame (b) and the surrounding shielding (c).
Secondary collimator (jaws)
The jaws were modelled with SYNCJAWS CM. They comprise two pairs of
high-Z material, such as lead or tungsten ([10]) (manufacturer proprietary
information), blocks, downstream from the mirror and mirror frame with the
surrounding shielding structure. First there are the Y jaws in an inplane
direction, and downstream there are the X jaws in a crossplane direction. The
jaws are the first component from the top in the treatment head that are
considered to be patient-specific beam-modifying components, which means
that any rectangular field size ranging between 0 x 0 cm2 and 40 x 40 cm2 can
be collimated with them. The Y jaws move about an arc, with the origin being
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in the X-ray target, the jaw edge always being parallel to the radial line drawn
through the X-ray target. The X jaws move along a horizontal line, pivoting so
that the jaw edge is parallel to the Y jaws. The geometrical equations to
calculate the jaw positions in the jaw level from the positions at the isocentre
(SSD = 100 cm) level defined by the TPS were implemented into a separate
script. The feature that allows the synchronised movement of the jaws with
other components, the source and the phantom is described in Section 3.1.2.2.
MLC
The MC MLC model of Varian Millennium 120 MLC consists of 60 pairs of
separate leaves made of high-Z material (manufacturer proprietary
information), modelled with SYNCVMLC CM. The MLC is the most complex
structure to model of the beam-modifying components. The detailed model
takes into account separately with different leaf types the tongues and grooves
and driving screw holes. In addition, for round leaf ends, the leaf curvature
radius has to be set, as does the focus point for the focused leaves (i.e. if the
imaginary lines drawn through leaf edges intersect at one point), and the
interleaf air gap for all leaves. The MLC positions for the simulations are
usually extracted from the TPS, which defines them at the isocentre level.
Again, as with jaws, this information was converted to the MLC level using the
isocentre ratio, which is the SSD divided by the distance from the source level
to the MLC level. However, due to issues related to the differences in the
apertures defined by the field light and radiation beam, defined by the rounded
leaf ends, i.e. the isocentre ratio changes as a function of the aperture size, the
geometrical equations based on the work by Boyer et al. ([151]) were further
empirically verified, taking into account the individual calibration of the MLC.
The results of the required individual benchmarking of the MC MLC model
(Figure 9 (a)-(b)) are shown in Section 5.1.
Figure 9. The MC MLC model (a) from the side and (b) from the BEV.
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Light field reticle plastic sheet
The last component from the top in the beam path for the photon beam is the
light field reticle and the plastic sheet. The thin sheet made of plastic
(manufacturer proprietary information) was modelled with SLABS CM.
Interface mount
To complement the photon beam treatment head MC model, the interface
mount directly below the light field reticle plastic sheet was modelled with
PYRAMIDS CM. The dimension of the aperture and structures were manually
measured and a medium-Z material was assigned.
Electron applicator with square cutout
To complement the electron beam treatment head MC model, in addition to the
interface mount, the electron applicator with an electron cutout was modelled.
The dedicated APPLICAT CM was not utilised in this study, since the bevelled
edges of the scrapers and cutout cannot be modelled with the CM ([20]).
Therefore, the more general purpose PYRAMIDS CM was applied (Figure 10).
The first and second scrapers were assigned a medium-Z material and the third
scraper was replaced by the cutout material, which is a modified version of
Cerrobend-type low melting point alloy ([152-153]) (manufacturer proprietary
information).
Figure 10. The electron applicator with square cutout.
Figure 11 (a)-(b) shows the complete treatment head models. The jaws have
been oriented in same direction for visualisation purposes. The MC geometry
models for both photon and electron beams and all beam energies are identical
for the following components: primary collimator, vacuum exit window, dual
monitor IC, mirror with its frame and surrounding shielding, jaws, MLC, light
field reticle plastic sheet and interface mount.
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Figure 11. Varian Clinac iX MC geometry models for (a) the photon and (b) the
electron beam (for explanation, see text).
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4.2. Benchmarking the MC model against
measurements – PDDs and profiles in water
phantom
One of the goals of this work was to build MC geometry models that would
represent the modelled linac as realistically as possible. Once the models were
assembled, the next step was to determine the initial electron beam and other
simulation parameters. With regard to EGSnrc-based physics modelling
(Section 3.1.1.), the goal was also to simulate the radiation transport as
realistically as possible, without many compromises, to reduce calculation
times, for example. The parameters shown in Table 3 were selected with
BEAMnrc code system version 2013 in all simulations.
Table 3. EGSnrc physics modelling parameters used in this study.
EGSnrc MC transport parameter Value
Global ECUT 0.521/0.561/0.700 MeV
Global PCUT 0.01 MeV
ESTEPE 0.25
XIMAX 0.5
Boundary crossing algorithm EXACT
Skin depth for BCA 3
Electron-step algorithm PRESTA-II
Spin effects On
Brems angular sampling KM
Brems cross-sections NRC
Triplet production On
Bound Compton scattering On
Compton cross-sections default
Radiative Compton corrections Off
Pair angular sampling KM
Pair cross-sections NRC
Photoelectron angular sampling On
Rayleigh scattering On
Atomic relaxations On
Electron impact ionisation On
Photon cross-sections xcom
Some of the chosen values represent the default values of the system ([20]), but
for many parameters, for which the default value is ‘off’, the option ‘on’ has
been selected. For Global ECUT there were three values, for which an
explanation is that in all the other simulations than in the DOSXYZnrc (0.700
MeV) and BEAMnrc phase space B (0.561 MeV) (see Section 4.3.) simulations
performed in [III], the value was 0.521 MeV. Many of the parameter choices
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are claimed to be significant only at low energy ranges, but since there is no
exact upper limit for this energy range and there is always a low energy
component present in the simulations, the options were turned on to better
reflect the realistic radiation transport ([20,154]).
After selecting the EGSnrc parameters, the iterative initial electron beam
parameter tuning was performed. The scheme described in Section 3.2. was
applied. It was commenced by tuning the initial electron beam spectrum, the
mean energy to be precise, for the 10 x 10 cm2 field with photon beams and the
A20 applicator for the electron beams (which defines a 20 x 20 cm2 field  at
SSD = 100 cm). Once a match for PDD was found, an energy spectrum with a
3% FWHM spread was applied to represent the mechanical energy slit present
in the bending magnet system that absorbs electrons falling outside this energy
range. The beam profiles were matched for the same field sizes by varying the
initial electron beam width FWHM value and the divergence. Concurrently, the
matches for the PDDs were monitored, and the energy spectrum was modified
as well, if needed. With photon beams, the beam profiles were also bench-
marked for varying depths and field sizes. The calculation grid sizes were
adapted to account for the varying dose gradients, being small (from 0.05 cm to
0.1 cm) in high dose gradient regions and greater in other regions. The reported
statistical uncertainties were less than 0.2% in PDD curves, less than 0.5% in
high dose regions in dose profiles, and from 1% to 2% in dose profile out-of-
field regions. The measured and calculated PDD curves were normalised to the
depth of 10 cm with photon beams and to dmax with electron beams. The dose
profiles were normalised to 100% at a measured or calculated value, which was
an average of three to five values around the beam CAX.
All the reference PDD measurements were performed using a motorised
scanning system in a PTW MP3 (PTW Freiburg GmbH, Germany) water
phantom. A PTW TM31002 Semiflex 0.125 cm3 IC (PTW Semiflex IC) (PTW
Freiburg GmbH, Germany) served as reference detector with a 6 MV photon
beam for 10 x 10 cm2 and 30 x 30 cm2 fields and for a 3 x 3 cm2 field an IBA
unshielded stereotactic semiconductor field detector (model DEB050) (IBA
SFD) (IBA Dosimetry AB, Sweden) was used. In addition, to study the
performance of the MC model in the build-up dose modelling, the build-up
dose for the 10 x 10 cm2 field for 6 MV photon beam was point-measured in
Gammex Standard Grade Solid Water® 457 (Gammex/RMI, Middleton, WI,
USA) with Gafchromic® EBT radiochromic film (Ashland Specialty
Ingredients, Wilmington, DE, USA). Therefore, the reference PDD curve was a
combination of interpolated film measurement data and IC measurement values.
With the 18 MV photon beam, the PTW Semiflex IC was used as reference
detector for all PDD measurements. With electron beams the reference PDD
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curves were measured with an IBA unshielded electron semiconductor field
detector (model DEB000) (IBA EFD) (IBA Dosimetry AB, Sweden).
In the dose profile measurements, the IBA SFD was used as a reference
detector for 3 x 3 cm2 fields with photon beams, while the PTW Semiflex IC
was utilised for other field sizes. With photon beams, the measurement depth
was 10 cm. With electron beams the dose profile data was measured at dmax
with the PTW Semiflex IC for 9/16 MeV beam energies, and with IBA EFD for
6/12 MeV beam energies, in order to study the applicability of both detectors
for electron beam dose profile measurements for QA purposes.
Figure 12. Benchmarking results for the 6 MV photon beam MC model: (a)-(b) PDD
and dose profile for 3 x 3 cm2 field, (c)-(d) PDD and dose profile for 10 x 10 cm2 field
and (e)-(f) PDD and dose profile for 30 x 30 cm2 field.
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For the 6 MV photon beam MC model, the results for the benchmarking are
presented in Figure 12. In PDDs the discrepancies were less than 0.5% of Dmax
at depths greater than 1.0 cm (dmax = 1.4 cm), usually being from 0.1% to 0.2%
of Dmax, especially for the 10 x 10 cm2 field. From the depth of 1.0 cm towards
the surface the differences increases, which is due to the MC model producing
greater PDD values than the IBA SFD and smaller PDD values than the EBT
film and the PTW Semiflex IC. In the dose profiles, when neglecting the
penumbral regions, the discrepancies were generally less than 0.5% of Dmax,
apart from several points in the dose profile for 10 x 10 cm2 field. In
penumbrae, the DTA values were 0.2 mm for the smallest field and less than
1.0 mm for larger fields.
Figure 13. Benchmarking results for the 18 MV photon beam MC model: (a)-(b) PDD
and dose profile for 3 x 3 cm2 field, (c)-(d) PDD and dose profile for 10 x 10 cm2 field
and (e)-(f) PDD and dose profile for 30 x 30 cm2 field.
0
20
40
60
80
100
0 5 10 15 20 25 30 35
Depth (cm)
R
el
at
iv
e
do
se
(%
)
-2.0
-1.0
0.0
1.0
2.0
D
iff
er
en
ce
(M
ea
s.
-M
C
)(
%
)(a)
0
20
40
60
80
100
0 5 10 15 20 25 30 35
Depth (cm)
R
el
at
iv
e
do
se
(%
)
-2.0
-1.0
0.0
1.0
2.0
D
iff
er
en
ce
(M
ea
s.
-M
C
)(
%
)(c)
0
20
40
60
80
100
-10 -8 -6 -4 -2 0 2 4 6 8 10
Distance off-axis X (cm)
R
el
at
iv
e
do
se
(%
)
-6.0
-4.0
-2.0
0.0
2.0
4.0
6.0
D
iff
er
en
ce
(M
ea
s.
-M
C
)(
%
)(d)
0
20
40
60
80
100
0 5 10 15 20 25 30 35
Depth (cm)
R
el
at
iv
e
do
se
(%
)
-2.0
-1.0
0.0
1.0
2.0
D
iff
er
en
ce
(M
ea
s.
-M
C
)(
%
)(e)
0
20
40
60
80
100
-22 -18 -14 -10 -6 -2 2 6 10 14 18 22
Distance off-axis X (cm)
R
el
at
iv
e
do
se
(%
)
-6.0
-4.0
-2.0
0.0
2.0
4.0
6.0
D
iff
er
en
ce
(M
ea
s.
-M
C
)(
%
)(f)
0
20
40
60
80
100
-6 -4 -2 0 2 4 6Distance off-axis X (cm)
R
el
at
iv
e
do
se
(%
)
-6,0
-4,0
-2,0
0,0
2,0
4,0
6,0
D
iff
er
en
ce
(M
ea
s.
-M
C
)(
%
)
(b)
38
With the 18 MV photon beam, the benchmarking results for the MC model are
presented in Figure 13. In PDDs the discrepancies were less than 1.0% of Dmax
at depths greater than 1.0 cm (dmax = 3.0 cm), usually being from 0.2% to 0.4%
of Dmax, especially for the 10 x 10 cm2 and 30 x 30 cm2 fields. From the depth
of 1.0 cm towards the surface the differences increase, which is due to the MC
model producing smaller PDD values than the PTW Semiflex IC. For the dose
profiles the discrepancies were less than 0.5% of Dmax. In penumbrae the DTA
values are 0.3 mm for the smallest field and less than 1.0 mm for larger fields.
An electron beam PDD curve has three parts: 1) the build-up region, where the
dose increases to the Dmax, 2) the ‘build-down’ region with large dose gradient,
where the dose diminishes, and 3) the flat contamination X-ray ‘tail’ of the
curve. Figure 14 shows the comparison data for the electron beam MC model.
For electron beam energies other than 6 MeV, the discrepancies in the build-up
region are less than 0.7% of Dmax. For the 6 MeV beam in the build-up region,
the MC model produces between 0% and 2.0% of Dmax higher PDD values than
the IBA EFD. In the dose ‘build-down’ region, the discrepancies are less than
1.0% of Dmax, being even smaller for 12 MeV and 16 MeV beams. In the X-ray
‘tails’ for all the beam energies, the discrepancies are small when compared to
measurements. In dose profiles the deviations are smaller than 0.3% of Dmax and
in penumbrae the DTA values are less than 0.5 mm for all energies.
The initial electron beam parameters for all the photon and electron beam MC
models are shown in Table 4. ISOURC = 19 was applied to all the MC models.
For the 6 MV photon beam, the final energy spectrum had a negatively skewed
Gaussian shape, having a lower energy ‘tail’, peaking at the energy of 5.9 MeV.
It did not differ much from the Gaussian energy spectrum, with 5.9 MeV mean
energy and 3% FWHM energy spread, but it produced slightly more congruent
results compared to some benchmarking measurements. For the 6 MV photon
and 16 MeV electron beam models the commissioning is partly presented in [I]
and for 6/18 MV photon and 9/16 MeV electron beam models in [149].
Table 4. The initial electron beam parameters for the MC models.
Parameter 6 MV 18 MV 6 MeV 9 MeV 12 MeV 16 MeV
Width,
FWHM (mm) 0.7 1.3 2.0 1.5 0.6 0.7
Mean angular
spread (º) 0.5 0.0 0.2 0.2 0.2 0.0
Energy
spectrum shape LinLog Gaussian Gaussian Gaussian Gaussian Gaussian
Mean energy,
(MeV) - 17.80 7.02 9.95 13.50 17.66
Energy spread,
FWHM (%) - 3.00 3.00 3.00 3.00 3.00
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Figure 14. Benchmarking results for the electron beam MC model: PDDs and dose
profiles for 6 MeV ((a)-(b)), 9 MeV ((c)-(d)), 12 MeV ((e)-(f)) and 16 MeV ((g)-(h)).
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4.3.  Absolute dose calibration
A monitor unit (MU) represents the radiation output of a linac. It is a measure
that is related to the calibration of the monitor IC and usually the definition is
that 100 MU is equivalent to a measured absolute dose of 1 Gray (Gy) in some
reference conditions, i.e. at reference SSD, with the reference field size and at
reference depth. This information is an integral part of the input data required
for TPS commissioning and the amount of radiation delivered by each field,
which is calculated by the TPS system, is transferred to the linac in MUs. [10]
In the BEAMnrc code system the calculated absorbed dose (in Gy) is
normalised by the number of particles from the original source, i.e. in the case
of linac simulations in this work, the number of electrons that are incident
originally on the X-ray target with photon beams and on the vacuum slab
replacing the X-ray target with electron beams. In order to perform full-scale
TPS benchmarking with the MC model, an absolute dose calibration of the MC
model is essential. In its simplest form, the user could simulate the dose
distribution to represent an absolute dose calibration measurement set-up,
determine the conversion factor with the MC-calculated dose in a voxel
representing the active volume of the detector, and use the factor to normalise
the dose distributions. However, with many types of linacs, as with the one used
in this work, the linac output is affected by the backscattered radiation from the
secondary and tertiary collimators, mainly from Y jaws, to the monitor IC.
Therefore, the required number of MUs accumulates sooner and the linac beam
is switched off earlier. This factor is included in the measured output factors,
which describe the field or aperture size dependence of the linac output. [2-
3,12] When output factors are determined with MC models, agreement levels of
1-3% over a broad field size range have been reported ([58,79,155-156]).
A formalism, with which the absolute dose calibration of the MC models in this
study is performed, is presented in [157]. The rigorous method is based on the
linac simulation in two steps. In the first simulation the phase space is collected
below all the fixed components in the treatment head (phspA), i.e. below the
mirror with the frame, surrounded by the shielding. In this simulation the dose
is scored in the active, charge-collecting air-filled volume of the monitor IC,
deposited by the forward-directed particles. In the second simulation the phspA
is used as a source and the geometry model includes the monitor IC and the
mirror with accompanying structures upstream from the source plane and all the
beam-modifying components, such as the jaws, the MLC and the electron
applicator, downstream from the source plane. The resulting phase space
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(phspB) located below all the treatment head components can thereafter be
utilised as a source in phantom dose calculations. In the phspB simulation the
dose is again scored in the monitor IC, as in phspA simulation, but now it
corresponds to the backscattered dose to the monitor IC, which is dependent on
the positions of the collimators. When performing these simulations in the
reference absolute dose measurements set-up, the relationship between the dose
calibration and MUs can be established for the MC model. This data can
subsequently be used with other field configuration simulations applying the
dose-MU equation according to [157].
In [157] the reported deviations between the measured and calculated square
field output factors were less than 1.5%. In this work, the output factors were
determined with the MC model for selected field sizes and compared to
measurements. The results are shown in Tables 5 and 6.
Table 5. The calculated and measured (IBA SFD (3 x 3 cm2) and PTW Semiflex IC
(10 x 10 cm2 and 30 x 30 cm2)) output factors for 6 MV and 18 MV photon beams with
percentage differences. The output factors are normalised to the value for 10 x 10 cm2
field.
3 x 3 cm2 30 x 30 cm2
Meas. MC Difference Meas. MC Difference
6 MV 0.868 0.873 0.61% 1.100 1.104 0.35%
18 MV 0.842 0.846 0.45% 1.088 1.094 0.51%
Table 6. The calculated and measured (PTW Roos TM34001 parallel plate IC) output
factors for 6 MeV, 9 MeV, 12 MeV and 16 MeV electron beams with percentage
differences. The output factors are normalised to the value for the field defined by the
A20 applicator.
A10 applicator
Meas. MC Difference
6 MeV 1.013 1.016 0.30%
9 MeV 0.985 0.988 0.26%
12 MeV 0.980 0.985 0.53%
16 MeV 0.976 0.981 0.49%
For all the MC models the discrepancies in the output factors are around or less
than 0.5%, when compared to the measurements. For both photon and electron
beams, the MC models produce larger output factors than the measurements.
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5. APPLICATION OF THE MONTE CARLO
MODELS TO SPECIFIC CASES IN
RADIOTHERAPY
5.1. Dosimetry
The MC models have been extensively used to provide more information on
various issues in dosimetry. Since the resolution of the calculated dose
distribution is very adaptable, calculation grids with small dimensions enable
the use of the MC models in small field/aperture dosimetry benchmarking. In
the commissioning benchmarking phase of the MC MLC model for this work, a
wide selection of detectors was used. First the evaluation was done with static
MLC-shaped fields to assess the accuracy of the various parameters defining
the MC MLC geometry model. To evaluate the accuracy of the geometric shape
and position of the leaves and leaf transmission in the MC model, separate
MLC-shaped fields in both crossplane and inplane directions were prepared and
measured. Since the apertures with single or few MLC leaves are small, high
resolution was a primary requirement for measurements. The most important
properties of the used detectors, in addition to the other detectors used during
the commissioning of the MC models, are presented in Table 7.
Table 7. Summary of detectors used and their most important properties.
* The film dosimetry system readout spatial resolution
The PTW Semiflex IC was partly used as the basic detector, but better
resolution was pursued with IBA SFD, Gafchromic® EBT2 radiochromic film
(Ashland Specialty Ingredients, Wilmington, DE, USA) and PTW microLion
PTW
Farmer
PTW
Semiflex
PTW
Roos
PTW
LIC
IBA
EFD
IBA
SFD
Gafchromic®
EBT2
Sensitive
material air air air
iso-
octane silicon silicon
radiochromic
film
Active volume
(mm3) 600 125 350 1.7 0.29 0.017 -
Active volume
size (mm) 6.1 5.5 15 2.5 2.0 0.6 0.8*
Density
(g/cm3) 0.001 0.001 0.001 0.692 2.329 2.329 1.2
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liquid-filled IC (LIC) (PTW Freiburg GmbH, Germany). Since there are
disadvantageous issues identified with all the detectors, the MC model was
compared to the most reliable detector in each field and field region, and if an
agreement was found, at the same time the MC model was used as a reference
for other detectors. The test field in Figure 15 (a) was to ensure the leaf
positions in crossplane and inplane directions (‘L-shaped’ field), and the final
static test field in Figure 15 (b) represented a complex-shaped field with
varying apertures (‘grid-shaped’ field).
Figure 15. BEV visualisations of test fields for the MC MLC model benchmarking: (a)
L-shaped and (b) grid-shaped field.
Figure 16. The relative crossplane dose profiles for the MC model and measurements
for the L-shaped field.
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Figure 17. The relative inplane dose profiles for the MC model and measurements for
the L-shaped field. The insert is a magnification of the out-of-field region.
In Figures 16 and 17 it can be seen that the MC MLC model is able to
reproduce the leaf positions defined by the test fields. The field aperture
penumbrae are congruent with all the measurement techniques. However, in the
out-of-field regions in both test fields, clear discrepancies are observable
between the measurement techniques. In the insert in Figure 17 there is a
magnification of this region – from 0 cm to +10 cm collimated by the MLC and
from +10 cm to +16 cm collimated by both the jaws and the MLC. The former
region benchmarks the MC model with regard to the interleaf leakage and leaf
transmission. The insert also shows that the dose profile pattern due to interleaf
leakage is effectively reproduced by the MC MLC model, when compared to all
measurements. For the leaf transmission, the MC MLC model coincides with
the LIC. The LIC was tested against PTW Semiflex IC with a jaw-collimated
square field out-of-field region and an agreement of 0.2% of Dmax was found.
This suggests that the leaf transmission is correctly modelled with the MC MLC
model, while the IBA SFD and Gafchromic EBT2 are found to over- and
underestimate the dose levels, respectively. In the latter region the jaw
collimation is added and the LIC and the MC model are also congruent in this
region, while the IBA SFD overestimates the dose level. These results are partly
found in preliminary form in [158].
45
Figure 18. The relative inplane dose profiles for the MC model and measurements for
the grid-shaped field.
Figure 18 presents the profiles for the complex-shaped test field. The limited
resolution of the PTW Semiflex IC due to the volume averaging effect is clearly
seen, especially in the apertures and closures of one leaf pair. In the leaf
closures and out-of-field regions, the IBA SFD shows similar overestimation as
the L-shaped field, but in the apertures it produces the best congruence with the
MC model because of the smallest size of the active volume in the detector. The
Gafchromic EBT2 film is congruent with the LIC in regions close to the beam
CAX, but it shows dose underestimation, especially in leaf apertures further
away from the beam CAX. The LIC shows the best overall congruence with the
MC model throughout the dose profile.
While the rigorously commissioned MC model can be used as a reference in
small field/aperture dosimetry for various detectors, it is also a choice of
reference method for dynamic MLC fields. For this purpose a highly modulated
IMRT field was prepared (Figure 19 (a)). The field dose distribution was first
measured using an IC array detector (IBA I’mRT MatriXX, IBA Dosimetry
AB, Sweden), consisting of 1020 ICs placed in a 32 x 32 grid, with 0.7619 cm
spatial resolution. The field was simulated with the MC model in virtual water
phantom with a similar spatial resolution. The dose distributions were
0
20
40
60
80
100
-15 -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0
Distance off-axis Y (cm)
R
el
at
iv
e
D
os
e
(%
)
Semiflex IC SFD EBT2 MC LIC
46
interpolated to a finer grid (0.1 cm x 0.1 cm) and normalised to the same
average dose value in a small flat dose region. Then, a 2D gamma comparison
with a 3% dose difference and a 3 mm DTA (3%/3 mm) acceptance criteria was
applied ([159-160]). Of all the analysed grid points, 98.6% fulfilled the criteria.
Figure 19. (a) A 3D visualisation of the IMRT field used in benchmarking. (b) shows
the relative dose profiles in an inplane direction for the MC model, and the film
dosimetry system is shown by the black line with arrows in (c), which is a 2D gamma
map where the red areas are the points that do not fulfil the acceptance criteria.
However, since the IC array detector suffers from relatively coarse spatial
resolution, when fields with small apertures are to be measured, the MC model
was applied to the benchmarking of a Gafchromic EBT2 film dosimetry system,
which was based on an in-house-built densitometer ([161]). The IMRT field
shown in Figure 19 (a) was measured with the system and simulated with the
MC model. In MC simulation the calculation grid size was 0.08 cm x 0.08 cm,
which was equivalent to the film dosimetry system readout grid size. Both dose
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distributions were smoothed using the 3 x 3 matrix median filter, converted to
grids of 0.1 cm x 0.1 cm by linear interpolation and normalised to give 100% at
the point of maximum dose. The 2D gamma analysis was performed with an
acceptance criteria of 3%/3 mm, for which the resulting gamma map is shown
in Figure 19 (c). Of all the analysed grid points, 94.3% fulfilled the criteria. In
the upper portion of the map there is a horizontal region (shown with arrows),
where a large portion of values not fulfilling the criteria is located, which is
most probably due to a minor malfunction in a single leaf motion. When
leaving that region out of the analysis, 96.6% of the points fulfil the criteria.
The dose profiles in Figure 19 (b) show the agreement between the MC model
and the film dosimetry system.
5.2. Photon beam dose calculation
The challenges related to the accuracy of dose calculation in the presence of
low-density materials are emphasised in the SBRT of the lung. In the SBRT of
the lung, small field apertures are delivered from multiple directions and in
most cases the fields propagate notable distances in the lung tissue prior to
impinging on the volume to be treated. For this purpose, three clinical photon
beam dose calculation algorithms of different generations, implemented in a
commercial radiotherapy TPS, Varian Eclipse™ version 10.0 (Varian Medical
Systems Inc., Palo Alto, CA, USA), were benchmarked. [II] The Pencil Beam
Convolution (PBC) algorithm is an analytical correction-based ‘type a’
algorithm, in which the dose is calculated by convoluting the field intensity
fluence with narrow pencil beam kernels. Subsequently, corrections for patient
surface obliquity and heterogeneities are performed. [162-164] The PBC
algorithm represented the first generation of the evaluated algorithms and it was
used in dose calculations for the SBRT of the lung from 1999 to 2011 at Tays.
The Analytical Anisotropic Algorithm (AAA) is a semi-analytical model-based
‘type b’ algorithm, although its core is built on exploiting pencil beams. The
pencil beams are derived from MC simulations, fitted to user-supplied beam
measurements, after which three separate sub-sources – primary photons, extra-
focal photons and electron contamination – are modelled. Heterogeneity
correction in the AAA is partly similar to the one in the PBC algorithm, but to
some extent, it also takes the scattered radiation from the surroundings of the
calculation point into account, i.e. in the lateral scaling of the medium it applies
six independent exponential functions to account for the lateral transport of
energy with varying densities. [165-167] The AAA represented the second
generation of the evaluated algorithms and it has been used in dose calculations
for the SBRT of the lung since 2011 at Tays. The Acuros XB (AXB) algorithm
is a non-analytical model-based ‘type c’ algorithm (see definition in [III]),
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which deterministically solves the coupled system of LBTEs. It uses the same
sub-source models as implemented in the AAA, but in the patient dose
calculation the following steps are performed: 1) transport of source model
fluence into the patient, 2) calculation of scattered photon fluence in the patient,
3) calculation of scattered electron fluence in the patient, and 4) dose
calculation. In the AXB algorithm the heterogeneity correction explicitly
models the physical interactions of radiation with matter and thus the report
mode for the final dose distribution is referred to as dose-to-medium in medium
(Dm,m). Although the AXB algorithm inherently calculates Dm,m, the dose
distributions can be converted to dose-to-water in medium (Dw,m), which is
performed by replacing the medium-based fluence-to-dose response function
used in absorbed dose calculation with a water-based response function. In the
PBC algorithm and in the AAA, the dose report mode is also Dw,m, but in those
algorithms the dose results are based on electron density-based corrections
applied to dose kernels calculated in water. [11,168-169] The AXB algorithm
represented the third, most recent generation of the evaluated algorithms and it
is currently in its commissioning phase at Tays. [II]
Dose distributions from full MC simulations were regarded as a reference for
the accuracy assessment. The first phase of the study included four patients
diagnosed with varying-sized central lung tumours. For the patients, treatment
plans that applied the 3D-CRT technique using 6 MV photon beams were made
using the AXB algorithm. The planning criteria were in accordance with the
Nordic SBRT study group, adapted from the original work published in [170].
The plans were recalculated (with same number of MUs and identical field
settings) using the MC model. To assess the accuracy of the AXB algorithm,
the original AXB-calculated dose distributions were compared to the MC-
calculated dose distributions with 3D gamma comparison with 3%/3 mm and
2%/2 mm acceptance criteria and with the dose volume histogram (DVH)
parameter comparison. [II]
An example of an SBRT plan isodose distribution recalculated with the MC
model is shown in Figure 20 (a). In general, the agreement between the AXB
algorithm and the MC model was good for larger planning target volumes
(PTVs). The 3D gamma agreement index (GAI) was over 99% and 94% for
both plans with acceptance criteria 3%/3 mm and 2%/2 mm, respectively. For
plans with smaller PTVs, the discrepancies were greater, especially for the plan
with PTV of 15.1 cc in size (Figure 20 (b)). However, the GAI result with 3%/3
mm criteria was over 95% for both plans. With DVH parameters for the OARs
the deviations were 1.5% or less for all plans. The largest differences occurred
with the DVH parameters for the PTV. [II]
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Figure 20. (a) The isodoses calculated by the MC model for the plan with medium-
sized PTV. There are six dose levels starting from 5 Gy in 10 Gy increments from the
outermost isodose curve. (b) A sagittal plane showing coloured areas where the gamma
calculation typically failed (threshold criteria 3%/3 mm). The graphs along the lines
show the percentage dose difference between the MC-recalculated AXB plan and the
original AXB plan. Lines in the profiles represent the PTV and the GTV (gross tumour
volume) boundaries. [II]
Figure 21. Comparison of the results for the algorithms as a function of the PTV size.
Lines with triangles represent the differences for D95%, D50% and D5% between the AAA
and the AXB-recalculated AAA-plan and lines with circles represent the differences
for D95%, D50% and D5% between the PBC algorithm and the AXB-recalculated PBC-
plan. Solid lines are for D95%, grey lines for D50% and dashed lines for D5%. [II]
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In the second phase of the study, treatment plans for ten patients with varying-
sized PTVs were prepared using the TPS algorithms. Applying the 3D-CRT
technique separate plans with both the PBC algorithm and the AAA were made
to meet the planning criteria. Both plan sets were recalculated with the AXB
algorithm and comparisons with original plans were performed. The TPS
algorithm comparison results showed large dose discrepancies in the PTV mean
dose (D50%), nearly 60%, for the PBC algorithm and differences of nearly 20%
for the AAA, occurring also in the small PTV size range, which is also shown
in Figure 21. With DVH parameters for the OARs the deviations were 1.6% or
less and 3.8% or less for the AAA and the PBC algorithm for all plans,
respectively. [II]
At the other end of the density range, according to the first results in other
studies, the AXB algorithm has been reported to reduce the uncertainties related
to the dose calculation in the presence of high-Z materials closer to a clinically
acceptable level. Therefore, in [III] the clinical benefit of the AXB algorithm
was demonstrated in a phantom and with a clinical example for the treatment of
a prostate cancer patient with a hip implant. In the first phase the AXB
algorithm was benchmarked against point and film dosimetry in an
anthropometric phantom ([171]) (Figure 22) with a unilateral hip implant and
also against the MC model, which was concurrently validated against the
measurements. The effect of the CT artefacts was quantified by performing the
calculations with the original CT dataset and corrected CT dataset, where
constant HU values were assigned, where applicable. [III]
Figure 22. The phantom and a beam from the side, through the stem of the hip
implant. Contoured cavities for the IC are also present. [III]
Scanditronix Wellhöfer FC65-G Farmer-type 0.6 cm3 IC (Farmer IC) (IBA
Dosimetry AB, Sweden) and IBA SFD were used as measurement detectors.
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Figure 23 shows the results for the corrected CT dataset. For the Farmer IC, on
average, the AXB algorithm underestimated the measured dose, with deviations
in both CT datasets ranging from -1.1% to -2.2%, being smaller for the
corrected CT dataset on average. With the MC model the overall discrepancies
compared to measurements were smaller, the differences ranging from -0.9% to
+0.7% in both CT datasets. [III]
Figure 23. Measured (Farmer IC and IBA SFD) and calculated (the AXB algorithm
and the MC model) depth dose values applying a 6 MV beam through the hip implant
in the corrected CT dataset. The highlighted region represents the implant. The inset
shows the magnification of the dose values in proximity to the implant and water
interfaces. [III]
With the IBA SFD, the AXB algorithm underestimated the measured and the
MC-calculated doses in the shadow of the implant. The deviations with both CT
datasets ranged from -5.5% to +2.2% and the mean differences were -2.4% and
-2.5% for the original and corrected CT datasets, respectively. When compared
to measurements, the overall discrepancies with the MC model were smaller,
the differences ranging from -3.1% to +0.1%. However, the AXB algorithm
was congruent with the MC model upstream and inside the implant. In the
proximal interface of the implant, the peak in the dose distribution was due to
the increased backscatter from the high-Z material to the lower density material
and it was modelled similarly by both the AXB algorithm and the MC model.
[III]
The clinical benefit of the AXB algorithm was assessed in the second phase of
the study. A clinical treatment plan was prepared for a prostate cancer patient
with a unilateral hip implant using the VMAT technique with avoidance sectors
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and static beams passing through the implant (referred to as the hybrid
technique). The plan was recalculated with the MC model and the dose
distribution was compared to the original AXB-calculated dose distribution to
assess the accuracy of the AXB algorithm in a clinical setting with beams
traversing the implant. A recalculation with the AAA was also performed to
quantify the benefit of the improved dose calculation accuracy of the AXB
algorithm over the AAA. [III]
The discrepancies between the AXB algorithm and the MC model were small.
The 3D GAI result with an acceptance criteria 2%/2 mm between the AXB
algorithm and the MC model was over 99%. In the DVH parameter
comparison, in general, the AXB algorithm showed a small underestimation
when compared to the MC model. The small discrepancies are visible in the
isodose distributions shown in Figure 24. The DVH parameter results for the
AAA showed small deviations from the results of the MC model, similar to the
results of the AXB algorithm. However, in the vicinity of and inside the
implant, the AAA produced greater deviations than the AXB algorithm when
compared to the MC model. [III]
Figure 24. The isodose curves for clinical patient plan demonstration calculated both
by the AXB algorithm (a) and the MC model (b). Isodose levels from the outermost
curve are 10%, 30%, 50%, 70%, 95% and 100% of the prescribed dose (PTV white).
[III]
5.3. Electron beam dose calculation
Various intensity-modulated photon beam treatment techniques have replaced
electron beams in many cases. Despite this, when treating the chest wall (post-
mastectomy or intact chest) the application of electron beams is still considered
a suitable option in terms of the resulting dose distribution. Great care should be
taken when the electron beam is directed so that the beam CAX is parallel or
close to parallel to the lung/mediastinum interface. This is because many of the
commercial dose calculation algorithms are known to assume slab-like
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geometry when calculating the dose in each voxel. Therefore, near the interface
large dose uncertainties are expected. For this purpose, the calculation accuracy
was tested for the Generalized Gaussian Pencil Beam (GGPB) algorithm (based
on the pencil beam principle) and the electron MC (eMC) algorithm (based on
the macro MC (MMC) principle), both implemented in the Varian Eclipse™
TPS. Preliminary and partial results are presented in [172]. The analytical
GGPB algorithm is based on the Fermi-Eyges electron multiple scattering
theory ([173-174]). The eMC algorithm, a Varian specific implementation of
MMC in Eclipse™ TPS, utilises a large library of pre-calculated kernels using
accurate MC simulations for spherical volumes of varying sizes, materials and
energies. The kernels are then used in the MC simulation within the global CT-
based patient geometry and the dose calculation is performed with an adaptive
step-size algorithm ([175-176]). [IV]
First the MC models for 9 and 16 MeV electron beams were commissioned, as
described in Sections 4.1-4.2. A comparison was made of the MC models
against the measurements in water. Then the GGPB and eMC algorithms were
benchmarked against the MC model in two virtual phantoms: 1) a water
phantom, where a lung-equivalent slab covering the whole area of the phantom
was immersed, and 2) a water phantom, where a lung-equivalent slab covering
half of the phantom area was immersed (Figure 25). Finally, the beams with
both energies were applied to an anthropomorphic phantom (RANDO) and in-
phantom thermoluminescence dosimetry (TLD) was performed at selected
points. The measurement results were compared to a CT-based dose
distribution calculation by the MC model. The accuracy of the GGPB and the
eMC algorithms was assessed by comparing it to the MC model simulation and
the measurements. [IV]
Figure 25. The phantom with a half lung-equivalent slab immersed in a water-
equivalent phantom at a depth of 3 cm (9 MeV beam) (a) or 4.5 cm (16 MeV beam)
(b). The locations of planes selected for calculating profiles chosen for comparison are
also shown. [IV]
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For the both beam energies (Figures 26 and 27), the dose profiles calculated
with the eMC algorithm show similar shapes to those calculated by the MC
model. However, in the lung-equivalent material the dose values calculated by
the eMC algorithm are 3-5% of Dmax higher than the reference results of the MC
model. In addition, in the dose profile at a shallower depth with the 9 MeV
beam energy, the eMC algorithm results also overestimate the dose over the
water-equivalent part by up to about 4% of Dmax. In regions where the dose
gradient is small, i.e. further away from the material boundary, the results of the
GGPB calculation in the presence of heterogeneity correction lead to dose
distributions closer to the MC model results, compared to results obtained from
eMC calculations. Anyhow, in the vicinity of the material boundary, in the
lung-equivalent region, the GGPB-calculated dose is 6-12% and 3-14% of Dmax
lower than in the MC-calculated dose profile for the 9 and 16 MeV beam
energies, respectively, and over the water-equivalent region it is higher by about
12% and over 15% of Dmax for the 9 and 16 MeV beam energies, respectively.
Figure 26. Dose profiles for the 9 MeV beam through the CAX in the phantom in
Figure 25 at depths of 4.4 and 5.2 cm, calculated by the MC (blue, solid line), eMC
(purple, circles) and GGPB (green, triangles) algorithms. [IV]
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Figure 27. Dose profiles for the 16 MeV beam through the CAX in the phantom in
Figure 25 at depths of 7.4 and 10.0 cm, calculated by MC (blue, solid line), eMC
(purple, circles) and GGPB (green, triangles) algorithms. [IV]
Figure 28 (a)-(e). PDD curves along white lines in (e) in RANDO anthropomorphic
phantom. The PDD curves shown are for the MC model (blue, solid line), eMC
(purple, circles) and GGPB (green, triangles) algorithms. The TLD point dose values
(red, diamonds) with their error bars are the white dots shown in (e). [IV]
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In the RANDO anthropomorphic phantom, the agreement for the eMC
algorithm is better than for the GGPB algorithm when compared with the
reference dose distribution calculated by the MC model and measured with
TLD (Figure 28 (a)-(e)). In general, the eMC algorithm slightly overestimates
the dose, by no more than 5% of Dmax (the maximum overestimation at depth of
4.5 cm in Figure 28 (b)). The GGPB algorithm underestimates the dose in many
regions, especially in the lung (by up to 15% of Dmax), but performs better in the
tissue-equivalent parts of the PDDs. In the DVH analysis for the lung in the
RANDO phantom, with the prescription dose of 50 Gy being 100%, the V20Gy
values (volume fraction with absorbed dose higher than 20 Gy) were 23.3% and
28.2% for the GGPB and eMC algorithms, respectively.
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6. DISCUSSION
6.1. The MC model for open and MLC-shaped beams
and dosimetry applications
A prerequisite for the application of MC simulations as a reference method for
various purposes is to develop a treatment head geometry and beam model,
with which the disagreement against the reference linac measurement data
would be as small as possible. In this work the manufacturer’s data on the
construction details of the reference linac were interpreted with great care
(taking into account the reported tolerances), readily accessible components
were measured and inconsistent information was sorted out by contacting the
manufacturer. For those parameters on which no information was available and
no measurements were possible, the initial values were gathered from other
studies and the final values resulted from an iterative fine-tuning process.
Special attention was paid to the acquisition of accurate reference measurement
data. First the measurements and the MC model fine-tuning was performed for
the reference field sizes used in QA activities at Tays and then for small and
large fields. The deviations from the measurements with PDDs were within
0.5% and 1.0% of Dmax at depths greater than 1.0 cm for the 6 MV and 18 MV
photon beams, respectively, being mostly between 0.0% and 0.5%. The largest
discrepancies in PDDs were for the small field with the 18 MV photon beam. In
general, the deviations in PDDs were small compared to other studies. Often, an
acceptable congruence has been considered to be found if the discrepancies are
less than 1-2% ([12,41,72-73,76-77]). The largest deviations in the dose build-
up region, near the phantom surface, suggest that the MC model most likely
produces a better estimate of the surface dose, since there are more uncertainties
related to the measured build-up doses. This is supported by other studies where
better congruence has been reported, when special attention has been paid to the
reference measurement equipment selection and set-up ([42-43,81]). With the
Gafchromic EBT film measurements, the combined uncertainty originated from
the determination of the actual measurement depth of the film active volume,
the non-water equivalence of the Gammex solid water, and the issues related to
film calibration. With the PTW Semiflex IC, the active volume averaging effect
of the detector caused uncertainties in the steep dose gradient region present in
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the dose build-up region, similar to the dose profile penumbrae. The congruence
in the dose build-up region was better for the 6 MV photon beam small field,
for which the PDD was measured with the IBA SFD, because of the negligible
volume of the detector active volume. With electron beams the deviations in
PDDs were smaller with increasing nominal beam energy, generally being less
than 1.0% of Dmax, which is similar to or less than that found in other studies
([105-107]). This suggests that the smaller the nominal energy, the more
sensitive the MC model is to simulation parameter selection. On the other hand,
with lower nominal beam energies the issues related to the accuracy of the
measurement detector positioning, the EPOM selection and the effect of the
detector active volume size are more pronounced.
In the dose profiles the congruence was good, mostly within 0.5% of Dmax in
high dose regions and out-of-field regions. The DTA values in penumbrae were
less than 0.5 mm for small fields with photon beams and with all electron beam
dose profiles, and less than 1.0 mm for large photon beam field sizes, due to the
volume averaging effect of the PTW Semiflex IC. Again, these deviations are
smaller than those accepted or achieved in other studies, in which the reported
discrepancies were often 1-3% in high dose regions and 1-2 mm DTA in
penumbrae ([41,72,77,105-107]). With output factors, including the
contribution of the backscatter to the monitor chamber through the absolute
dose calibration described in Section 4.3., the deviations were mostly about or
less than 0.5%. These discrepancies are small when compared to the results
obtained in other studies ([41,72,79,105,108]). All in all, the performance of the
MC model in this study in a water phantom, where the reference measurement
data of relatively good accuracy is achievable, has been shown to be as good or
better than that reported in other studies. The merit of the MC models is that
both the photon beam and the electron beam geometry models are based on
identical common components of the treatment head ([I]), which in combination
with the benchmarking results indicate that the MC models represent the
realistic linac used as reference.
The MC model built for open beams, i.e. for beams collimated only with the
jaws, is insufficient for TPS QA purposes in modern radiotherapy. Therefore,
the MLC model in the MC model was separately commissioned and bench-
marked. The complexity of the MLC and the related geometry model
introduced the need to include several various field configurations for testing.
At the same time, the requirements for the reference measurement data
acquisition became more demanding, since the test fields contained very small
apertures and sharp dose gradients, both in 1D and 2D and in static and
dynamic mode. The performance of the MC model was assessed by comparing
the calculated dose profiles to those measured dose profiles that were
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considered to represent the most accurate measurement data in each test field
and separate test field region. The pros and cons of each detector were taken
into account, such as the very high spatial resolution but the oversensitivity to
scattered radiation of the IBA SFD. The MC model showed congruent results
with the measurements, similar to other studies ([88-89,94,158]) and on the
other hand, thus served as a reference for measurements. The performance of
the MC model with dynamic MLC fields was assessed, simulating a complex
‘sliding window’ dynamic MLC field and comparing the calculation results to
measured dose distributions by an IC array detector and film dosimetry system
([161]). The comparison to the IC array detector showed congruent results, but
due to the coarse spatial resolution of the measurement, the comparison with
the film dosimetry system was essential. The deviations from the film
dosimetry system were small, and simultaneously the MC model provided
reference data for benchmarking the film dosimetry system. As shown in other
studies ([92,96-99]), rigorous commissioning of the MC MLC model is a
necessity for obtaining dose distributions with the MC model that can be further
used for more advanced purposes. However, an issue that needs to be taken into
account is that in measurements which include large dose gradients or areas of
charged particle disequilibrium, the measurement uncertainty is increased and
even if the MC model were to produce congruent results, the measurement
uncertainty contributes to the resulting total uncertainty of the MC-calculated
dose distribution. In charged particle disequilibrium conditions, even a perfect
agreement between MC simulation and a single dosimetric method does not
imply that the result is definitely the best. The performance needs to be assessed
against general properties of the dosimetric methods (i.e. detector
size/resolution, water equivalence and sensitivity to spectral changes) in
specific measurement conditions.
The commissioning of the MC-based treatment head geometry and beam model
contains a large number of parameters. Despite this, the manufacturers provide
detailed geometric and material information for many of the components, there
is still a notable number of complete components and parameters that have to be
determined by the user by measuring or otherwise iteratively tuning. In
addition, the above-mentioned data provided by the manufacturer often contains
tolerances that increase the number of iterations needed in the commissioning
process. All these uncertainties result in the fact that the final configuration of
the MC model is always a unique solution for a single reference linac and the
output that has been used for reference measurement data acquisition. This also
means that there is no single correct configuration, i.e. when slightly changing
some parameter values, the effects may cancel each other out and the combined
result is a dose distribution that is similar to the original results within the
statistical uncertainty. This also introduces a pitfall, because the variation of
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some parameters may not affect the calculated dose distributions in a similar
way to the variation of some other parameter. This can be overcome by
performing comprehensive and rigorous benchmarking for the MC model,
naturally focusing on acquiring reference measurement data of the highest
possible accuracy at first. The related uncertainties in the MC model could also
be reduced if the manufacturers were to provide even more detailed information
on the initial electron beam and treatment head components, especially those
contributing to the extra-focal component of the radiation beam emerging from
the treatment head. This would perhaps further improve the build-up dose
modelling, as suggested in [41]. Moreover, the CMs in the BEAMnrc code
system are not fully sufficient for modelling all the necessary components and
especially their movement in the treatment head. Examples of such are the tilted
mirror with its frame and surrounding shielding structure and the jaws, of which
one pair of blocks moves in an arc and the other one pivots around a certain
point.
6.2. The application of the MC model to specific clinical
cases in radiotherapy
When TPS QA or patient plan verification is pursued, a major advantage of MC
models is that they inherently produce 3D dose distributions of the desired
resolution in a virtual or CT-based 3D calculation phantom of choice. This is
contrary to measurement-based methods, where the dose distributions are often
projected to 2D. Even if the measurement device were to produce 3D
measurement data, the dose distribution for comparison purposes is generally
recalculated in measurement phantoms that are different from the original ones,
and the perturbations introduced by the measurement detectors are also to be
taken into account.
To explore and exploit the benefits of the MC methods in TPS QA purposes,
the MC model commissioned in this study was used to assess the accuracy of a
commercial TPS in several clinical cases ([II][III][IV]). The performance of the
TPS dose calculation algorithms in tissues with lower density than the density
of the water has always been of interest, especially after the introduction of
SBRT to the treatment of malignancies of the lung. The main aim in [II] was to
assess the accuracy of a new ‘type c’ photon beam dose calculation algorithm in
comparison to two other, ‘type a’ and ‘type b’, TPS algorithms in the SBRT of
the lung. However, first the ‘type c’ algorithm was benchmarked against the
MC model. The results in [II] suggest that, as already shown in other studies,
the PBC algorithm (‘type a’) should not be applied in dose calculation for the
SBRT of the lung, since it overestimates the dose in the PTV, especially for
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plans with small PTVs. The deviations between the AXB algorithm (‘type c’)
and the AAA (‘type b’) were small for the plans with large PTVs, but
discrepancies were found with the plans with small PTVs. Interestingly, for
certain plans the results suggested that the AAA produced dose distributions
closer to the ones calculated with the MC model than the AXB algorithm. In
other studies ([169,177-178]), the AXB algorithm has been shown to provide
equally or even more accurate dose distributions than the AAA in virtual slab
phantoms and in both anthropomorphic and patient phantom geometries, which
was not fully supported by the results of [II] for patient phantom geometries.
The AXB algorithm version utilised in [II] requires more comprehensive
benchmarking prior to clinical commissioning, especially for the SBRT of the
lung, and the comparisons in [II] need to be reassessed in order to quantify the
effect of the reported improvements of the algorithm included in the next
version ([179]). Therefore, in [II] it was suggested that independent plan
verification, such as full MC dose calculation and/or measurements, should be
applied, when the AAA or the AXB algorithm are utilised in the SBRT of the
lung having PTVs smaller than 20-25 cc. However, the calculated data in [II]
can be used, in addition to similar contributions from other studies by the
radiotherapy community, in adjusting the SBRT protocols based on ‘type a’
and/or ‘type b’ algorithms for the most recent generation, ‘type c’ algorithms,
such as the AXB algorithm.
The challenges in the TPS dose calculation in the presence of high-Z materials,
for example, in the form of a hip implant, have influenced the whole of
treatment planning in general. This is because usually such treatment beam
directions have been avoided where the beams first traverse the implant prior to
impinging on the volume to be treated. This has resulted in less optimal dose
distributions with respect to the PTV and OARs when compared to patients
with no hip implants. However, the previously reported improved dose
calculation accuracy of the AXB algorithm in the presence of high-Z materials
has been suggested for overcoming this issue and therefore in [III] it was
benchmarked against the MC model, also providing a comparison to the AAA.
The clinical benefit of the algorithm was demonstrated with a prostate cancer
patient with a unilateral hip implant, for whom a treatment plan using hybrid
VMAT technique was drawn up. According to the findings in [III], the AXB
algorithm was shown to agree well with the MC model and the measurements,
as already seen in [11] and [180]. With the clinical example plan, the
discrepancies between the MC model and the AXB algorithm were small, with
the MC model producing slightly higher doses than the AXB algorithm. This
was quantitatively confirmed by the GAI value and through comparison with
corresponding DVH parameter results. This means that in addition to phantom
calculations, the AXB algorithm is a reliable choice for clinical dose calculation
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with patient plans including hip implants, where the beams traverse high-Z
material. The AAA showed relatively good congruence with the MC model and
the AXB algorithm in the PTV and OARs, but due to the discrepancies in the
vicinity of and inside the implant, the use of the AAA is discouraged in clinical
situations similar to those presented in [III]. In addition, [III] was also the first
study where the accuracy of the AXB algorithm applying the VMAT technique
was assessed by comparing to full MC simulations.
With the electron beams the clinical dose calculation has also suffered from
large uncertainties in the presence of materials, the density of which has
considerably differed from the density of water. In [IV] a special case, when an
electron beam is directed towards the chest wall so that the beam CAX is
parallel or close to parallel to the lung/mediastinum interface, was studied. The
accuracy of two TPS dose calculation algorithms was benchmarked in various
slab and anthropomorphic phantom geometries against measurements and the
MC model. The results of [IV] suggested that the MC-based eMC algorithm
provides improved dose distributions when compared to the pencil beam-based
GGPB algorithm, which significantly underestimates the lung dose and
overestimates the dose to the mediastinum in the studied case. In general, the
results in [IV] are consistent with the findings in other studies ([123,181-182]).
However, there were discrepancies between the eMC algorithm and the MC
model in the virtual phantom calculations. It suggests that the performance of
the eMC algorithm should be further assessed, especially with the more recent
versions of the algorithm, and that an independent plan verification should be
applied, for example, with full MC simulations and/or measurements, when the
eMC algorithm is used with studied patient geometry.
The built and benchmarked MC model for photon and electron beams in this
study has been shown to provide reference-level dose distributions in both
virtual and CT-based phantoms for dosimetry and TPS benchmarking purposes.
The reported deviations in a water phantom between the MC model and the
measurements were small in both photon and electron beams in general, when
compared to other studies, where usually only photon or electron beams and a
smaller set of beam energies are covered. In addition, the consistency between
the MLC-shaped test field measurements and the MC model simulation results
was good, taking into account the issues related to the measurement accuracy.
All the simulations were performed with a large number of particle histories,
which minimised the effect of statistical uncertainties on the results. In addition,
the use of variance reduction techniques was kept to the minimum, so that they
would introduce minimal bias to the results. These in turn minimised the effect
of the systematic uncertainties, i.e. the latent variance ([183]), introduced
through the utilisation of intermediate phase space files, to the calculated dose
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distributions. The effect was further decreased by using the shared library
feature in the BEAMnrc system, where applicable. All in all, the achieved
accuracy of the MC model to simulate beams from the treatment head was
considered to be adequate for further purposes, where dose distributions need to
be simulated in various phantom geometries.
In addition to default materials included in the PEGS4 cross-section data
library, additional data was produced to take into account all the known
material compositions and densities present in the treatment head and phantom
simulations. This allowed a more meaningful comparison between the MC
model, the measurements and the TPS calculations. In CT-based calculations,
the correspondence between the HU values and densities is taken into account
through a conversion curve and the material assignment is performed utilising
the curve. In this study the conversion curve was determined with great care
and identical curves were used in the MC model calculations and in the TPS.
This is an important issue in enabling the assessment of actual dose calculation
accuracy between the calculation methods. Furthermore, since the MC model
inherently calculates the Dm,m whereas most of the clinical TPS dose calculation
algorithms calculate the Dw,m, the systematic differences introduced due to dose
reporting mode have to be taken into consideration in comparisons. The
differences are small, 1-2%, for tissues with densities close to water, but for the
bone, for example, the discrepancy may reach 15% ([2]). The issue can be
overcome by converting the dose distributions between the dose reporting
modes as post-processing step without introducing noteworthy approximations
to the results ([184]).
Since the statistical fluctuations are inherent characteristics of MC-based dose
distributions, the point dose-based approach in dose comparison may result in
erroneous conclusions. Instead, integrated dose quantities, such as DVH
comparison, are recommended. However, if point dose values are used, a low
level of statistical uncertainty should be pursued. [2] One option is also to
perform denoising for dose distributions utilising a method that would represent
an optimal trade-off between smoothing the fluctuations due to statistical noise
and real variation in dose levels. [185-186] Another argument for applying
denoising is to reduce the number of histories that need to be simulated in order
to attain the desired level of statistical uncertainty, which in turn decreases the
calculation time ([186]). Long calculation times, which have traditionally been
the major drawback related to MC methods, were not given special attention in
this study, that is, the number of particle histories and other simulation
parameters were chosen so that the calculation accuracy was optimised.
64
The MC model in this study has been proved to function as a dose calculation
tool for QA purposes. Virtual phantoms of any material and rectilinear shape
can be built to represent idealised calculation geometries, whereas CT-based
calculation phantoms can be used to mimic the clinical treatment planning
process with the related issues. The MC model can be applied as reference for
various dosimetric devices measuring the delivered dose distributions, or the
MC model may fully replace the measurements in TPS QA and treatment plan
verification. In addition, another interesting application for the MC model is the
linac QA, where the beam delivery and movements are simulated based on log
files ([139]). In the future, it is expected that clinical dose calculations will be
based on full MC simulations. However, one challenge with this is the
application of the MC techniques in solving inverse problems applied in plan
optimisation. One possible solution is to combine the deterministic calculation
techniques that are powerful in inverse problem calculations with the accuracy
of the MC techniques that can be used in the intermediate and final dose
distribution calculations. As the dose distributions based on full MC
simulations are considered to represent the ‘reality’, they can also be used for
retrospective dose calculations, for patients for which the treatment outcome,
local tumour control and normal tissue complications are known. This
information may further be used for adjusting the treatment protocols and thus
pursuing more favourable clinical outcomes.
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7. CONCLUSIONS
The invincible dose calculation accuracy of full MC simulations cannot be
exploited prior to thorough commissioning of the MC model that includes
detailed configuration and benchmarking. Despite this, some of the most
popular codes, such as the BEAMnrc system, are user-friendly with their GUIs,
but the user has to have knowledge of the parameters with which the underlying
physics transport, geometry model and other simulation options are governed.
The rigorous benchmarking process requires a wide collection of accurate
reference measurement data, including all the beam energies, various field
sizes, phantom geometries and measurement detectors/methods, against which
the MC model is iteratively fine-tuned. However, previously published results
on the BEAMnrc system, which has been effectively tested among the
radiotherapy community, give good information on the assets and pitfalls
related to the simulations.
The good accuracy level of the model that was achieved was confirmed through
comparisons against measurements in water in different circumstances, both
with square fields and more complex MLC-shaped static and dynamic fields.
The results of output factor comparison attested to the validity of the absolute
dose calibration of the MC model that is essential, especially in TPS
benchmarking.
The MC model was applied to accuracy testing of the TPS in certain clinical
cases. The results of this study have shown that even the most advanced TPS
algorithms are not always able to reach clinically acceptable accuracy levels,
when large heterogeneity differences are present. This, especially in
combination with new treatment techniques, establishes the demand for further
verification techniques, such as full MC simulations. With photon beams, in the
SBRT of the lung – apart from small differences in general – the most recent
generation TPS dose calculation algorithm was shown to disagree with results
of the MC model in certain cases, whereas the algorithm from the previous
generation provided more congruent results with the MC model. The
differences suggest that independent plan verification is needed in the SBRT of
the lung with plans having small PTVs. With high-Z materials the most recent
generation TPS dose calculation algorithm provided clinically acceptable
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results against the MC model both in phantom, when verified against
measurements, and with a patient plan, when the beam traverses the implant,
whereas the use of a TPS dose calculation algorithm from the previous
generation is discouraged. However, with other high-Z materials than that used
in our study, the most recent generation TPS dose calculation algorithm has to
be benchmarked separately, also taking the artefacts in the CT datasets into
account. With electron beam TPS dose calculation algorithms, the MC model
was used to assess the accuracy of two TPS algorithms at a tissue heterogeneity
interface parallel to the beam CAX. The most recent generation algorithm
provided more congruent results with the MC model than the other algorithm,
which was also verified by the anthropomorphic phantom measurements.
Despite this, such differences were discovered in flat dose regions that further
improvements are anticipated in future versions of the most recent generation
algorithm. In conclusion, there is a definite need for the MC model to provide
reference dose distributions for the commissioning of new dosimetric methods,
and for patient plans in which the current clinical TPS algorithms are known to
generate large dosimetric uncertainties. In addition, the MC model is exploited
to benchmark new dose calculation algorithms to be commissioned.
The utilisation of the MC model described in this study, in addition to the TPS
configuration data validation performed, represents the type of use that most
directly benefits the clinical radiotherapy community and has the most
straightforward effect on the total uncertainty involved in radiotherapy.
However, the real strength of the MC methods lies in the fact that they can be
adapted to meet any applications where dose distributions of reference-level
accuracy are needed. Also, it is only a matter of time when all the radiotherapy
treatment planning dose calculations are performed applying full MC
simulations.
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C.1 The AXB algorithm vs. the full MC model
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C.2 The performance of the TPS algorithms
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0& FRGH
VLPXODWLRQVSRLQWGRVLPHWU\LQDZDWHUSKDQWRPDQGGRVHGLVWULEXWLRQVFDOFXODWHGLQYLUWXDOSKDQWRPV
)RU WKH0H9HOHFWURQEHDP WKHDFFXUDF\RI WKHVHDOJRULWKPVZDVDOVRFRPSDUHGRYHU WKH OXQJ
PHGLDVWLQXP LQWHUIDFH UHJLRQ RI DQ DQWKURSRPRUSKLF SKDQWRP DJDLQVW 0& FDOFXODWLRQV DQG
WKHUPROXPLQHVFHQFH GRVLPHWU\ 7/' ,Q WKH SKDQWRP ZLWK D VODE RI OXQJHTXLYDOHQW PDWHULDO WKH
UHVXOWV RI DOO FDOFXODWLRQV ZHUH JHQHUDOO\ FRQJUXHQW WKH H0& UHVXOWV IRU WKH 0H9 EHDP VOLJKWO\
RYHUHVWLPDWLQJWKHOXQJGRVHDQGWKH**3%UHVXOWV IRUWKH0H9EHDPXQGHUHVWLPDWLQJWKHOXQJ
GRVH 2YHU WKH VLPXODWHG OXQJPHGLDVWLQXP LQWHUIDFH IRU  DQG  0H9 EHDPV WKH **3% FRGH
XQGHUHVWLPDWHGWKHOXQJGRVHDQGRYHUHVWLPDWHGWKHGRVHLQZDWHUFORVHWRWKHOXQJFRPSDUHGWRWKH
FRQJUXHQWH0&DQG0&UHVXOWV,QWKHDQWKURSRPRUSKLFSKDQWRPUHVXOWVRI7/'PHDVXUHPHQWVDQG
0& DQG H0& FDOFXODWLRQV DJUHHG ZKLOH WKH **3% FRGH XQGHUHVWLPDWHG WKH OXQJ GRVH *RRG
DJUHHPHQWEHWZHHQ7/'PHDVXUHPHQWVDQG0&FDOFXODWLRQVLQWKHDQWKURSRPRUSKLFSKDQWRPDWWHVWV
WRWKHDFFXUDF\RI³IXOO´0&VLPXODWLRQVDVDUHIHUHQFHIRUEHQFKPDUNLQJFRGHVXVHGLQFRPPHUFLDO
736V $SSOLFDWLRQ RI WKH **3% FRGH LQ FKHVW ZDOO HOHFWURQ EHDP WKHUDS\ SODQQLQJ PD\ UHVXOW LQ
VLJQLILFDQW XQGHUHVWLPDWLRQ RI GRVH WR WKH OXQJ DQG RYHUHVWLPDWLRQ RI GRVH WR WKH PHGLDVWLQXP
DIIHFWLQJWKHUDS\SODQRSWLPL]DWLRQRYHUYROXPHVFORVHWRWKHOXQJPHGLDVWLQXPLQWHUIDFHVXFKDVWKH
OXQJRUKHDUW

3HUIRUPDQFHRIWZRHOHFWURQEHDPDOJRULWKPVLQFKHVWZDOOUDGLRWKHUDS\


1. Introduction
(OHFWURQEHDPVFDQEHDSSOLHGLQH[WHUQDOEHDPUDGLRWKHUDS\WRWUHDWWXPRXUYROXPHVDGMDFHQWWRWKHVNLQRU
DW VKDOORZ GHSWKV WR EHVW H[SORLW WKH GHSWKGRVH FKDUDFWHULVWLFV RI VXFK EHDPV >@ ,Q PRGHUQ WUHDWPHQW
SODQQLQJV\VWHPV736VPRVWRIWKHDOJRULWKPVXVHGWRFDOFXODWHGRVHGLVWULEXWLRQVIURPHOHFWURQEHDPVDUH
EDVHG HLWKHU RQ SHQFLO EHDP RU RQ0RQWH&DUOR 0& SULQFLSOHV 7KH SHQFLO EHDP DOJRULWKPV XVHGPRVW
IUHTXHQWO\ DUH WKH*HQHUDOL]HG*DXVVLDQ3HQFLO%HDP **3% >@ WKH*DXVVLDQ3HQFLO%HDP >@ DQG WKH
5HGHILQLWLRQSHQFLOEHDPDOJRULWKPV>@,Q0&DOJRULWKPVRIFRPPHUFLDO736VVHYHUDOWHFKQLTXHVDUHXVHG
WR VSHHGXS WKHLU FDOFXODWLRQV ,Q WKH0DFUR0RQWH&DUOR 00&DOJRULWKP SUHFDOFXODWHG VPDOO YROXPH
HOHPHQWV>@>@DUHDSSOLHG7KHYR[HO0RQWH&DUORDOJRULWKP>@>@XVHVDFROOHFWLRQRIYDULDQFHUHGXFWLRQ
WHFKQLTXHV DQG GLIIHUHQW DSSUR[LPDWLRQV LQ PRGHOOLQJ YDULRXV LQWHUDFWLRQ SURFHVVHV:KHQ WHVWHG DJDLQVW
PHDVXUHPHQWV LQ KRPRJHQHRXV SKDQWRPV DW VWDQGDUG VRXUFHWRVXUIDFH GLVWDQFHV 66' WKH DFFXUDF\ RI
PRVWRIWKHVHDOJRULWKPVLVVDWLVIDFWRU\+RZHYHU0&EDVHGDOJRULWKPVDUHUHSRUWHGWRVKRZEHWWHUDFFXUDF\
LQPRUHFRPSOH[KHWHURJHQHRXVJHRPHWULHV>@>@>@>@

7KHDFFXUDF\RIHOHFWURQEHDPGRVHFDOFXODWLRQDOJRULWKPVXVHGLQFRPPHUFLDO736VKDVEHHQWHVWHGDJDLQVW
PHDVXUHPHQWV DQG UHVXOWV RI ³IXOO´0& FDOFXODWLRQV LQ VPDOO DLU FDYLWLHV VPDOO ERQH SULVPV ORFDO RXWHU
FRQWRXU YDULDWLRQV VWHS QRVH FRQWRXU HWF WKH WUDFKHDO FDYLW\ RU WKH YHUWHEUDH >@>@>@>@>@
3KRWRQEHDP LQWHQVLW\PRGXODWHG UDGLRWKHUDS\KDVE\QRZZLGHO\ UHSODFHGHOHFWURQEHDPV LQ WKH FOLQLFDO
WUHDWPHQWRIVXFKVLWHV\HWLQWUHDWLQJWKHFKHVWZDOOSRVWPDVWHFWRP\RULQWDFWFKHVWDSSOLFDWLRQRIHOHFWURQ
EHDPVPD\VWLOORIIHUDFOLQLFDODGYDQWDJH7KHDFFXUDF\RI736HOHFWURQEHDPDOJRULWKPVRYHUDGMDFHQWOXQJ
YROXPHVKDVEHHQ WHVWHGEXWPDLQO\ IRU VODEOLNHJHRPHWULHV >@>@>@7RFRPSDUH WKHKHDUWDQG OXQJ
GRVHVDVVRFLDWHGZLWKFKHVWZDOOLUUDGLDWLRQRISDWLHQWVXQGHUJRLQJHOHFWURQEHDPERRVWWKHUDS\&ROHPDQHW
DO>@YDOLGDWHGDQLPSOHPHQWDWLRQRIWKHSHQFLOEHDPSULQFLSOH)HUPL(\JHV+RJVWURPDOJRULWKPDJDLQVW
DQ0&FDOFXODWLRQLQFKHVWZDOOWUHDWPHQWRIDQDQWKURSRPRUSKLFSKDQWRPE\D0H9HOHFWURQEHDP,Q
WUHDWPHQWRIWKHWKRUDFLFVHFWLRQRIDQDQWKURSRPRUSKLFSKDQWRPXVLQJD0H9HOHFWURQEHDP:DOLJRUVNL
HW DO >@ FRPSDUHG WKH DFFXUDF\ RI WZR HOHFWURQ SHQFLO EHDP DOJRULWKPV DJDLQVW WKHUPROXPLQHVFHQFH
GRVLPHWU\7/',QDQRWKHUPRUHUHFHQWVWXG\$XEU\HWDO>@FRPSDUHGFDOFXODWLRQUHVXOWVRIWKH9DULDQ
736LPSOHPHQWDWLRQRIWKH00&DOJRULWKPH0&IRUHOHFWURQEHDPVRIHQHUJLHVUDQJLQJEHWZHHQDQG
0H9 LQ VODEOLNH JHRPHWU\ DQG DQWKURSRPRUSKLF OXQJPHGLDVWLQXP LQWHUIDFH JHRPHWULHV DJDLQVW DQ0&
FRPSXWDWLRQ DQG ILOP PHDVXUHPHQWV 'XULQJ WKH SDVW GHFDGH DGYDQFHG 0& FRGHV HVSHFLDOO\
(*6QUF%($0QUF0&13DQG3(1(/23(KDYHHVWDEOLVKHGWKHLUDSSOLFDELOLW\LQTXDOLW\DVVXUDQFH4$
DQGEHQFKPDUNLQJFDOFXODWLRQVLQUDGLRWKHUDS\>@>@2IIHULQJ³IXOO´0&VLPXODWLRQVWKHVHFRGHVDUHQRZ
DEOH WR GHOLYHU UHIHUHQFHTXDOLW\ WKUHHGLPHQVLRQDO ' GRVH GLVWULEXWLRQV LQ FRPSOH[ KHWHURJHQHRXV
JHRPHWULHV

,QWKLVZRUNZHVWXGLHGWKHFDOFXODWLRQDFFXUDF\RIWKH**3%DOJRULWKPEDVHGRQWKHSHQFLOEHDPSULQFLSOH
DQGRIWKHH0&DOJRULWKPEDVHGRQWKH00&SULQFLSOHLPSOHPHQWHGLQWKH9DULDQ(FOLSVH736%RWK
DOJRULWKPVZHUHDSSOLHGWRWUHDWWKHUHJLRQRIWKHFKHVWZDOODQGOXQJFORVHWRWKHPHGLDVWLQXPLQQRQVODE
JHRPHWU\XVLQJ[FPILHOGVRIRU0H9HOHFWURQEHDPV:HILUVWFDOFXODWHGGRVHGLVWULEXWLRQVLQD
KRPRJHQHRXVZDWHUHTXLYDOHQWSKDQWRPDQG LQDVODESKDQWRPZLWKZDWHUDQG OXQJHTXLYDOHQWPDWHULDOV
5HVXOWVRI WKHVHFDOFXODWLRQVZHUHFRPSDUHGDJDLQVW UHVXOWVRID VLPXODWLRQXVLQJ WKH%($0QUF0&FRGH
SDFNDJHDQGYDOLGDWHGDJDLQVWPHDVXUHPHQWVLQDZDWHUSKDQWRPZLWKDQLRQL]DWLRQFKDPEHU,&DQGXVLQJ
UDGLRFKURPLF ILOP 1H[W ZH FRPSDUHG UHVXOWV REWDLQHG LQ D KHWHURJHQHRXV ZDWHUHTXLYDOHQW SKDQWRP LQ
ZKLFK D VHPLLQILQLWH OXQJHTXLYDOHQW VODE ZDV LPPHUVHG WR UHSUHVHQW WKH OXQJPHGLDVWLQXP ERXQGDU\
FRYHULQJKDOIRIWKHDUHDSHUSHQGLFXODUWRWKHEHDPD[LVDQGH[WHQGLQJIURPWKHHGJHRIWKHSKDQWRPWRWKH
EHDPFHQWUDOD[LV&$;)LQDOO\ERWKHOHFWURQEHDPDOJRULWKPVZHUHDSSOLHGWRFDOFXODWHFOLQLFDOO\UHOHYDQW
GRVH GLVWULEXWLRQV IURP D [ FP ILHOG RI D 0H9 HOHFWURQ EHDP LQ D &7EDVHG DQWKURSRPRUSKLF
SKDQWRP IRU FRPSDULVRQDJDLQVW UHVXOWV RI D%($0QUF0& UHIHUHQFH FDOFXODWLRQ DQGDJDLQVW LQSKDQWRP
7/'PHDVXUHPHQWV7KH GLIIHUHQFHV EHWZHHQ FDOFXODWHG DQGPHDVXUHG GRVH YDOXHVZHUH WKHQ DQDO\VHG WR
DVVHVVWKHSHUIRUPDQFHLQWHUPVRIDFFXUDF\RIWKHWHVWHG736DOJRULWKPVDSSOLHGWRFDOFXODWHHOHFWURQEHDP
GRVHGLVWULEXWLRQVRYHUDUHDVFORVHWRWKHOXQJPHGLDVWLQXPLQWHUIDFH

2. Materials and Methods 

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

2.1. Electron beam dose calculation algorithms 
7KH WHVWHG DOJRULWKPV **3% YHUVLRQ  DQG H0& YHUVLRQ  DUH LPSOHPHQWHG LQ WKH
(FOLSVH736 E\9DULDQ0HGLFDO 6\VWHPV ,QF 3DOR$OWR&DOLIRUQLD86$&RPPLVVLRQLQJ RI WKH
UHVSHFWLYH DOJRULWKPV ZDV SHUIRUPHG DFFRUGLQJ WR PDQXIDFWXUHU¶V PDQXDOV XVLQJ WKH VDPH PHDVXUHPHQW
GDWD ZKHUH DSSOLFDEOH 7KH DQDO\WLFDO **3% DOJRULWKP LV EDVHG RQ WKH )HUPL(\JHV HOHFWURQ PXOWLSOH
VFDWWHULQJ WKHRU\7KH XQFHUWDLQW\ RI WKH**3%DOJRULWKPFDQ EH HVWLPDWHG WREH  LQZDWHUHTXLYDOHQW
PHGLXP DQG  LQ ODUJH KHWHURJHQHRXV YROXPHV VXFK DV WKH OXQJ >@ 7KH H0& DOJRULWKP D 9DULDQ
VSHFLILF LPSOHPHQWDWLRQRI00&LQ(FOLSVH736XWLOL]HVDODUJH OLEUDU\RISUHFDOFXODWHGNHUQHOVXVLQJ
DFFXUDWH0&VLPXODWLRQVIRUVSKHULFDOYROXPHVRIYDU\LQJVL]HVPDWHULDOVDQGHQHUJLHV7KHNHUQHOVDUHWKHQ
XVHG LQ WKH 0& VLPXODWLRQ ZLWKLQ WKH JOREDO &7EDVHG SDWLHQW JHRPHWU\ DQG WKH GRVH FDOFXODWLRQ LV
SHUIRUPHGZLWKDQDGDSWLYHVWHSVL]HDOJRULWKP>@

7KHQRPLQDOHQHUJLHVRIWKHHOHFWURQEHDPVXVHGLQWKLVVWXG\ZHUH0H9Ē0  0H9Ep,0 0H9
Rp FPDQG0H9Ē0  0H9Ep,0 0H9Rp FPZKHUHĒ0LVWKHPHDQHQHUJ\DW
WKHSKDQWRPVXUIDFHEp,0 LVWKHPRVWSUREDEOHHQHUJ\DWWKHSKDQWRPVXUIDFHDQGRpLVWKHH[WUDSRODWHGUDQJH
RIWKHHOHFWURQEHDP>@7KH66'ZDVFP$SSOLFDWLRQRI0H9HOHFWURQEHDPVLVW\SLFDOIRUWUHDWLQJ
WKHSRVWPDVWHFWRP\FKHVWZDOOZKLOHEHDPVRIKLJKHUHQHUJ\ XS WR0H9DUHRIWHQDSSOLHG LQERRVW
WKHUDS\RIFRQVHUYDWLYHO\RSHUDWHGEUHDVWFDQFHU7KHFDOFXODWLRQJULGVL]HVIRU**3%DQGH0&FRGHVIRU
0H9 ZHUH  DQG  PP FORVHVW PDWFKLQJ FDOFXODWLRQ JULG VL]H ZLWK VPDOO YR[HO GLPHQVLRQV
UHVSHFWLYHO\DQGPPIRU0H9LQERWKDOJRULWKPV7KHODUJHUJULGZDVVHOHFWHGIRU0H9EHDPLQ
RUGHUWRXVHLGHQWLFDOJULGVLQERWKDOJRULWKPVDQGEHFDXVHRYHUOHVVVWHHSJUDGLHQWVODUJHUFDOFXODWLRQYR[HOV
FRXOGEHXVHG7KH H0&DOJRULWKPFRQWDLQV VHYHUDORSWLRQV7KH IROORZLQJRSWLRQVZHUH VHOHFWHG IRU WKLV
VWXG\Accuracy DYHUDJHVWDWLVWLFDOXQFHUWDLQW\LQWKHKLJKGRVHUHJLRQMaximum number of particle 
histories    DXWRPDWLFDOO\ GHWHUPLQHG WR UHDFKAccuracySmoothing method  1R VPRRWKLQJ >@$V
UHSRUWHGE\'LQJHWDO >@RU3RSSOHHWDO >@UHVXOWVRIH0&FDOFXODWLRQVPD\VWURQJO\GHSHQGRQWKH
VHOHFWLRQRIFDOFXODWLRQSDUDPHWHUVVXFKDVHJWKHVL]HRIWKHFDOFXODWLRQJULGDFFXUDF\RUVPRRWKLQJ

$ KRPRJHQHRXV ZDWHUHTXLYDOHQW SKDQWRP 3 ZDV ILUVW FUHDWHG ZLWKLQ WKH (FOLSVH 736 DQG D
FRPSDULVRQ ZDV PDGH RI GRVH GLVWULEXWLRQV FDOFXODWHG IRU  DQG 0H9 HOHFWURQ EHDPV XVLQJ WKH WZR
DOJRULWKPV 7KH HOHFWURQ DSSOLFDWRU VL]H ZDV $ SURGXFLQJ D [ FP ILHOG DW FP 66' 3HUFHQW
GHSWKGRVH3''FXUYHVDORQJWKH&$;FDOFXODWHGIRUHDFKHQHUJ\ZHUHFRPSDUHG

1H[W D YLUWXDO KHWHURJHQHRXV ZDWHUHTXLYDOHQW SKDQWRP 3 ZDV FUHDWHG FRQWDLQLQJ D VODE RI OXQJ
HTXLYDOHQW PDWHULDO PDVV GHQVLW\  J FP HTXDO WR WKH PDVV GHQVLW\ RI OXQJ PDWHULDO LQ WKH
DQWKURSRPRUSKLF5DQGR$OGHUVRQ70SKDQWRP)RU0H9EHDPFDOFXODWLRQVD OXQJHTXLYDOHQWVODERI
FPWKLFNQHVVZDVLQVHUWHGDWDGHSWKRIFPZKHUHWKHZDWHUHTXLYDOHQWWKLFNQHVVRIFPUHSUHVHQWVDFP
WKLFNZDWHUHTXLYDOHQWEROXVWRLQFUHDVHWKHVXUIDFHGRVHWRDQGDSRVWPDVWHFWRP\FKHVWZDOORIFP
ZDWHUHTXLYDOHQW WKLFNQHVV )RU  0H9 EHDP FDOFXODWLRQV WKH VODE ZDV SODFHG DW D GHSWK RI  FP
UHSUHVHQWLQJDZDWHUHTXLYDOHQWEROXVRIFPWKLFNQHVVWRLQFUHDVHWKHVXUIDFHGRVHWRDQGDFKHVW
ZDOORIFPZDWHUHTXLYDOHQWWKLFNQHVV7KHHIIHFWRIWKHULEVZLWKPDVVGHQVLW\DQGDWRPLFFRPSRVLWLRQRI
ERQHZDV LQFOXGHG LQ WKHZDWHUHTXLYDOHQWFKHVWZDOO WKLFNQHVV DVKHWHURJHQHLWLHV LQ WKHGRVHGLVWULEXWLRQ
GXHWRWKHULEVWUXFWXUHSURPLQHQWMXVWEHORZWKHULEVDUHPDUNHGO\UHGXFHGDWWKHGHSWKVRILQWHUHVWLQWKLV
VWXG\>@>@7KHWRWDOWKLFNQHVVRIWKH3SKDQWRPZDVWKHUHIRUHHTXDOWRRUFPIRUWKHDQG
0H9HOHFWURQEHDPFDOFXODWLRQV UHVSHFWLYHO\$JDLQ WKH$HOHFWURQEHDPDSSOLFDWRUZDVXVHG LQ WKHVH
FDOFXODWLRQV

$WWKHWKLUGVWDJHFDOFXODWLRQVXVLQJWKHWZR736HOHFWURQEHDPDOJRULWKPVZHUHSHUIRUPHGLQ\HWDQRWKHU
SKDQWRPJHRPHWU\ 3ZLWK WKH VODERI OXQJHTXLYDOHQWPDWHULDO PDVVGHQVLW\J FP LPPHUVHGDW
GHSWKV RI  FP IRU WKH  0H9 EHDP RU  FP IRU WKH  0H9 EHDP FRYHULQJ KDOI RI WKH DUHD
SHUSHQGLFXODUWRWKHEHDPD[LV$VVKRZQLQILJXUHWKHVODEH[WHQGHGIURPWKHHGJHRIWKHSKDQWRPWRWKH
&$;DQG WKH OXQJZDWHU LQWHUIDFHZDVSDUDOOHO WR WKHEHDPD[LV7KH$HOHFWURQDSSOLFDWRUSUHYLRXVO\
XVHG LQ WKH3DQG3FDOFXODWLRQVZDVDOVRDSSOLHGKHUH7ZRFURVVSODQHSURILOHV WKURXJK WKH&$;DW
GHSWKV ZKHUH ODUJHVW GLIIHUHQFHV EHWZHHQ WKH WZR 736 HOHFWURQ EHDP DOJRULWKPV RFFXU ZHUH FKRVHQ IRU
FRPSDULVRQ

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

FIGURE 1

)LQDOO\ GRVH GLVWULEXWLRQV RYHU WKH DQWHULRU FKHVW ZDOO RI D KHWHURJHQHRXV DQWKURSRPRUSKLF 5DQGR
$OGHUVRQ70 SKDQWRP 3 WUHDWHG E\ D  0H9 HOHFWURQ EHDP ZLWK DQ $ HOHFWURQ DSSOLFDWRU ZHUH
FDOFXODWHG XVLQJ WKH WZR736 HOHFWURQ EHDPDOJRULWKPV DQG WKH ³IXOO´0&PRGHO VHH EHORZ5HVXOWV RI
WKHVHFDOFXODWLRQVZHUHFRPSDUHGDJDLQVW7/'PHDVXUHGYDOXHVRIDEVRUEHGGRVHDWVHOHFWHGSRVLWLRQVLQVLGH
WKHOXQJDQGPHGLDVWLQXPDUHDVRIWKHDQWKURSRPRUSKLFSKDQWRP7KHDQWKURSRPRUSKLFSKDQWRPJHRPHWU\
XVHGLQWKHFDOFXODWLRQVDQGWKHSRVLWLRQVRI7/'GHWHFWRUVZHUHUHFRQVWUXFWHGIURPDVHWRIPPWKLFN&7
VOLFHVRIWKHSKDQWRPDWPPVOLFHVSDFLQJ

2.2. The BEAMnrc MC code package 
³)XOO´ 0& PRGHO VLPXODWLRQV ZHUH SHUIRUPHG XVLQJ WKH %($0QUF FRGH SDFNDJH YHUVLRQ 9 RU
%($0QUF  EDVHG RQ WKH(*6QUF0& FRGHZKLFK VLPXODWHV FRXSOHG HOHFWURQSKRWRQ WUDQVSRUW7KH
(*6QUFEDVHG SKDQWRP GRVH FDOFXODWLRQ LV SHUIRUPHGZLWK'26;<=QUF DOVR LQFOXGHG LQ WKH %($0QUF
FRGHSDFNDJH7KLVFRGHSDFNDJHZDVLQVWDOOHGRQWKHFDOFXODWLRQJULGRIWKH7DPSHUH&HQWUHIRU6FLHQWLILF
&RPSXWLQJ7&6&DWWKH7DPSHUH8QLYHUVLW\RI7HFKQRORJ\7877KHJULGFRQVLVWVRIFRUHV>@

7KH JHRPHWU\PRGHO RI WKH OLQHDU DFFHOHUDWRU WUHDWPHQW KHDGZDV EDVHG RQ WKH9DULDQ&OLQDF&'
PHGLFDO OLQHDU DFFHOHUDWRU 7KHPDQXIDFWXUHU SURYLGHG WKH DXWKRUVZLWK D FRQILGHQWLDO SURSULHWDU\ 0RQWH
&DUOR'DWD3DFNDJH+LJK(QHUJ\$FFHOHUDWRUFRQWDLQLQJLQIRUPDWLRQRQSDUDPHWHUVGHVFULELQJWKH
JHRPHWU\DQGPDWHULDOVUHTXLUHGLQWKHPRGHOOLQJSURFHVV>@7KHPRGHOLQFOXGHGWKHSULPDU\FROOLPDWRU
WKH YDFXXP H[LW ZLQGRZ GXDO VFDWWHULQJ IRLOV GXDO LRQL]DWLRQ FKDPEHUV WKH ILHOG PLUURU ZLWK LWV IUDPH
VXUURXQGHGE\WKHOHDGVKLHOGLQJSODWHMDZVWKHIXOO\UHWUDFWHGPXOWLOHDIFROOLPDWRUWKHOLJKWILHOGUHWLFOHWKH
DFFHVVRU\ PRXQW DQG WKH HOHFWURQ DSSOLFDWRU ZLWK D VTXDUH FXWRXW 0RVW RI WKH JHRPHWU\ GDWD ZHUH
LPSOHPHQWHGIURPWKHPDQXIDFWXUHU
VGDWDSDFNDJHEXWUHDGLO\DFFHVVLEOHWUHDWPHQWKHDGFRPSRQHQWVZHUH
DOVR UHPHDVXUHGZLWK DFDOLSHU ,Q DGGLWLRQ WR WKHGHIDXOW3(*6FURVV VHFWLRQGDWD IRUYDULRXVPDWHULDOV
LQFOXGHG LQ %($0QUF FXVWRP PDWHULDO ILOHV ZHUH FUHDWHG IROORZLQJ PDWHULDO VSHFLILFDWLRQV RI WKH GDWD
SDFNDJH (OLPLQDWLRQ RI VRPH REYLRXV HUURUV GLVFUHSDQFLHV DQG GHILFLHQFLHV LQ WKH 0& GDWD SDFNDJH
UHTXLUHGLQWHUSUHWDWLRQDQGDGGHGDGGLWLRQDOGHJUHHVRIIUHHGRPWRWKHPRGHO

$IWHUDQLWHUDWLYHLQLWLDOHOHFWURQEHDPSDUDPHWHUWXQLQJSURFHVVWKHLQLWLDOHOHFWURQEHDPZDVVHOHFWHGWREH
RIFLUFXODUVKDSHZLWKD*DXVVLDQLQWHQVLW\GLVWULEXWLRQRIPP):+0DQGPP):+0IRUWKHDQG
0H9EHDPVUHVSHFWLYHO\7KH LQLWLDOHOHFWURQEHDPHQHUJ\VSHFWUXPZDVDVVXPHGWREH*DXVVLDQZLWK
PHDQHQHUJLHVDQG0H9DQG):+0VSUHDGDWWKH;UD\WDUJHWOHYHOLQWKHWUHDWPHQWKHDG
1RYDULDQFHUHGXFWLRQWHFKQLTXHVZHUHXVHG7KHQXPEHURISDUWLFOHKLVWRULHVZDV[SHUVLPXODWLRQ
IRUHDFKHQHUJ\DQG WKHUHVXOWLQJSDUWLFOHGDWDZHUHFROOHFWHGLQWRDSKDVHVSDFH ILOHDWFP66'7KH
IROORZLQJ(*6QUFSDUDPHWHUVZHUHXVHGLQDOOVLPXODWLRQVECUT = AE 0H9PCUT = AP  
0H9ESTEPE   XIMAX   Boundary crossing algorithm  EXACT Skin depth forBCA   
Electron-step algorithm   PRESTA-II Spin effects   On Brems angular sampling   KM Brems cross 
sections   NIST Bound Compton scattering   norej Compton cross sections   default Pair angular 
sampling KMPair cross sections = BH; Photoelectron angular sampling = On; Rayleigh scattering = 
On; Atomic relaxations = On; Electron impact ionization = On; Photon cross sections xcom>@>@

7KHDERYHGLVFXVVHGSKDVHVSDFHGDWDZDVXVHGDVLQSXWIRUGRVHFDOFXODWLRQVLQWKHSKDQWRPVDSSO\LQJWKH
'26;<=QUF FRGH$W HDFK EHDP HQHUJ\ WKH QXPEHU RI SDUWLFOH KLVWRULHVZDV  [  SHU VLPXODWLRQ
ZKLFKUHTXLUHGWKHSDUWLFOHVWREHUHF\FOHGVHYHUDOWLPHV7KHVL]HVRIWKHFDOFXODWLRQYR[HOVZHUHDGDSWHGWR
EHVPDOOHULQUHJLRQVRIKLJKGRVHJUDGLHQWV,QRUGHUWRPDLQWDLQKLJKUHVROXWLRQWKURXJKRXWWKHGHSWKGRVH
DQGSURILOHFXUYHV WKHYR[HO VL]HVZHUHYDULHGEHWZHHQDQGFP2YHU UHJLRQVRI LQWHUHVW WKH0&
FDOFXODWLRQ YR[HO VL]HV ZHUH FRPSDUDEOH WR WKH FDOFXODWLRQ JULG VL]HV DSSOLHG LQ WKH **3% DQG H0&
DOJRULWKPV7KHUDQGRPQDWXUHRISDUWLFOHWUDQVSRUWLVH[SUHVVHGE\GHWHUPLQLQJVWDWLVWLFDOXQFHUWDLQWLHVIRU
WKH FDOFXODWHG GRVH YDOXHV ZLWKLQ HDFK YR[HO ,Q %($0QUF DQG '26;<=QUF VLPXODWLRQV WKH YDOXHV DUH
FDOFXODWHGXVLQJWKHKLVWRU\E\KLVWRU\PHWKRG>@7KHVHUHODWLYHHUURUVZHUHW\SLFDOO\OHVVWKDQEXW
VRPHZKDW H[FHHGHG WKLV YDOXH QHDU WKH VXUIDFH DORQJ WKH =D[LV DQG DW GLVWDO HQGV RI WKH SURILOHV 7KH

3HUIRUPDQFHRIWZRHOHFWURQEHDPDOJRULWKPVLQFKHVWZDOOUDGLRWKHUDS\

(*6QUFSDUDPHWHUVZHUHWKRVHXVHGLQWKHWUHDWPHQWKHDGVLPXODWLRQV3KDQWRPVVLPLODUWRWKRVHFUHDWHGIRU
WKH 736 DOJRULWKPV ZHUH FUHDWHG ZLWKLQ WKH '26;<=QUF XVLQJ 3(*6 FURVVVHFWLRQ GDWD IRU YDULRXV
PDWHULDOV VACUUM, AIR521ICRU DQG H20521ICRU7KHLUNG521ICRUGDWDZHUHPRGLILHG WRPDWFK
WKHPDVVGHQVLW\RIWKHOXQJPDWHULDOXVHGLQWKHH0&FDOFXODWLRQV7KHLQLWLDOHOHFWURQEHDPWXQLQJSURFHVV
DQGEHDPSDUDPHWHUVHOHFWLRQDUHGLVFXVVHGHOVHZKHUH>@>@>@>@>@$VDUHVXOWRIWKHWXQLQJSURFHVV
2MDODHWDO>@ZKHQFRPSDULQJUHVXOWVRI3''PHDVXUHPHQWVLQZDWHUWR0&PRGHOFDOFXODWLRQV
WKHPD[LPXPUHODWLYHGLIIHUHQFHVDWGHSWKVEH\RQGWKHGHSWKRIGRVHPD[LPXPGPD[ZHUHDQG
IRU WKH DQG0H9EHDPV UHVSHFWLYHO\ ,QSURILOHV DW GPD[  DQG FP IRU DQG0H9EHDPV
UHVSHFWLYHO\ WKHPD[LPXPGLVWDQFH WR DJUHHPHQW '7$YDOXHV LQ WKH SHQXPEUDHZHUH  DQGPP
DYHUDJHGRVHGLIIHUHQFHVLQWKHKLJKGRVHUHJLRQZHUHDQGDQGDYHUDJHGRVHGLIIHUHQFHVLQRXW
RIILHOGUHJLRQVZHUHDQGIRUWKHDQG0H9EHDPVUHVSHFWLYHO\)RUWKLVVWXG\VHWVRIGRVH
GLVWULEXWLRQ GDWD VLPLODU WR WKRVH REWDLQHG XVLQJ WKH FRPPHUFLDO 736 DOJRULWKPV ZHUH H[WUDFWHG IRU
FRPSDULVRQ

7KH0&GRVHFDOFXODWLRQ LQ WKH5DQGR$OGHUVRQ70SKDQWRPZDVFDUULHGRXW IRUD 0H9HOHFWURQEHDP
ZLWKDQ$DSSOLFDWRUZKLFKKDGEHHQHDUOLHUXVHG LQPHDVXUHPHQWV >@DQG66' FPLQD&7
EDVHGSKDQWRPJHRPHWU\ UHFRQVWUXFWHG IURPDVHWRIPPWKLFN&7VOLFHVZLWK WKH&7&5($7(FRGH LQ
'26;<=QUF7KH&7QXPEHUWRPDWHULDODQGPDVVGHQVLW\FRQYHUVLRQFXUYHZHUHGHILQHGXVLQJWKH50,
*DPPH[  7LVVXH&KDUDFWHUL]DWLRQ 3KDQWRP 0LGGOHWRQ:,86$ DQG 3(*6 FURVVVHFWLRQ GDWD IRU
5DQGR$OGHUVRQ70OXQJDQGWLVVXHPDWHULDOV>@

2.3. Comparative measurements and methods of data analysis 
0HDVXUHPHQWVWRYHULI\WKH3SKDQWRPFDOFXODWLRQVZHUHSHUIRUPHGXVLQJDQLRQL]DWLRQFKDPEHU,&LQD
03 ZDWHU SKDQWRP ZLWK D VFDQQLQJ V\VWHP 37: )UHLEXUJ *PE+ *HUPDQ\ 7KH 3'' FXUYH ZDV
HVWDEOLVKHGDFFRUGLQJWRWKH,$($756SURWRFRO>@XVLQJD37:5RRVSDUDOOHOSODWHLRQL]DWLRQ
FKDPEHURIFPYROXPHZLWKDQHPSLULFDOO\FRUUHFWHGHIIHFWLYHSRLQWRIPHDVXUHPHQW (3207KH
GHSWKGRVHGLVWULEXWLRQRYHUWKHEXLOGXSUHJLRQDQGWKH5GHSWKGHSWKDWZKLFKRIUHODWLYHGRVHLV
GHSRVLWHGZHUHSRLQWYHULILHG LQVROLGZDWHUZLWK*DIFKURPLF(%7UDGLRFKURPLF ILOP7KH3''FXUYHV
ZHUHDOVRXVHGDVDSDUWRIFRQILJXUDWLRQGDWDIRUH0&DQG**3%LQWKH(FOLSVH736

0HDVXUHPHQWVLQWKHDQWKURSRPRUSKLF5DQGR$OGHUVRQ70SKDQWRPZHUHSHUIRUPHGLQWKHWKRUD[VHFWLRQRI
WKLVSKDQWRPDWHOHYHQVHOHFWHGSRVLWLRQVLQWKHOXQJDQGWKHPHGLDVWLQXPUHJLRQVILJXUHHZKHUH7/'
GHWHFWRUV/L%20Q6LZHUHSODFHG7KH7/'GHWHFWRUVZHUHFDOLEUDWHGXVLQJD09SKRWRQEHDPLQD
VROLG ZDWHU SKDQWRP DW WKH GHSWK RI GRVH PD[LPXP 7KH GHWDLOHG SURFHGXUH RI 7/' PHDVXUHPHQWV LV
GHVFULEHG HOVHZKHUH >@$W VHOHFWHG SRLQWVZLWKLQ WKH SKDQWRP VOLFH WKUHH VWDFNHG7/'GHWHFWRUVZHUH
SODFHG FHQWUDOO\ LQ WKH PPGLDPHWHU KROHV DQG KHOG LQ SODFH E\ WLVVXHHTXLYDOHQW URGV >@7KH7/'
PHDVXUHG SRLQW GRVH YDOXHV ZHUH EDVHG RQ PHDQ YDOXHV RI WZR LQGHSHQGHQW H[SRVXUHV RI WKH 5DQGR
$OGHUVRQ70 SKDQWRP 2YHU WKH HOHFWURQ EHDP HQHUJ\ UDQJH  0H9 WKH PHDVXUHG LQWULQVLF HQHUJ\
GHSHQGHQFH RU UHODWLYH HIIHFWLYHQHVV RI /L%20Q6L7/'GHWHFWRUV ZLWK UHVSHFW WR DEVRUEHG GRVH LQ
ZDWHU RI 09 SKRWRQV UHPDLQV ZLWKLQ    >@ REYLDWLQJ WKH QHHG WR LQWURGXFH DQ\ HOHFWURQ
HQHUJ\FRUUHFWLRQWRWKH7/'UHDGRXWV

7KHGDWDZHUHDQDO\VHGDQGSORWWHGXVLQJDFXVWRPPDGH9%$EDVHGFRGHRSHUDWLQJZLWKLQWKH0LFURVRIW
([FHO 5HGPRQG:DVKLQJWRQ86$VSUHDGVKHHWDSSOLFDWLRQ)RUGRVHFRPSDULVRQVFRQFHUQLQJ WKH
3SKDQWRPWKH0&FDOFXODWHG3''VZHUHQRUPDOL]HGWRFRLQFLGHZLWKWKHPHDVXUHG3''FXUYHVDWGPD[
)RUGRVHFRPSDULVRQV LQ WKH3DQG3SKDQWRPV WKHDERYHGHWHUPLQHG3SKDQWRPQRUPDOL]DWLRQIDFWRUV
ZHUHXVHG7KH9%$EDVHGFRGHZDVDOVRXVHGWRFDOFXODWHUHODWLYHGLIIHUHQFHVEHWZHHQGRVHYDOXHVIURP
WKHGDWDVHWVFRPSDUHG

3. Results 
3.1. Homogeneous phantom (P1) 

3HUIRUPDQFHRIWZRHOHFWURQEHDPDOJRULWKPVLQFKHVWZDOOUDGLRWKHUDS\

0HDVXUHPHQWV RI WKH3''FXUYHVZHUH SHUIRUPHG DV D FRPELQDWLRQRI ILOPSRLQWPHDVXUHPHQWV RYHU WKH
GRVH EXLOGXS UHJLRQ DQGPHDVXUHPHQWV XVLQJ D SDUDOOHO SODWH LRQL]DWLRQ FKDPEHU ZLWK FRUUHFWHG (320
5HVXOWVRIWKHVHPHDVXUHPHQWVVHUYHGDVDFFXUDWHFRQILJXUDWLRQGDWDIRUWKHFRPPHUFLDODOJRULWKPVDQGDV
UHIHUHQFHGDWDIRUWKH0&PRGHO7KH3''FXUYHVQRUPDOL]HGWRDWGPD[DUHVKRZQLQILJXUHIRU
0H9DQG LQILJXUHIRU0H9HOHFWURQEHDPV7KHRYHUDOODJUHHPHQWEHWZHHQ WKHGLIIHUHQWFDOFXODWLRQ
PRGHOVDQGPHDVXUHPHQWVLVJRRG7KHDFFXUDF\RIWKH0&EHDPPRGHOZLWK$DSSOLFDWRUVL]HXVHGIRU
SKDQWRP3ZDVFRQILUPHGLQH[DFWO\WKHVDPHPDQQHUDVWKDWXVHGIRUWKH$DSSOLFDWRUZLWKLGHQWLFDO
UHVXOWVQRWVKRZQ

FIGURE 2

FIGURE 3

3.2. Heterogeneous phantom (P2) 
,Q FDOFXODWLRQV SHUIRUPHG IRU WKH 3 KHWHURJHQHRXV SKDQWRP WKH UHVXOWV RI WKH 0& FDOFXODWLRQ ZHUH
FRQVLGHUHG DV UHIHUHQFH VLQFH QR PHDVXUHG GDWD ZHUH DYDLODEOH 2YHU WKH KHWHURJHQHLW\ UHJLRQ WKH 0&
UHVXOWVVKRZPRUHGHWDLOLQWKH3''WKDQGRWKHH0&RU**3%UHVXOWVZKLFKLVGXHWRWKHGRVHFDOFXODWLRQ
SULQFLSOHV DQG WR GLIIHUHQFHV LQ JULG VL]HV )RU WKH 0H9 EHDP ILJXUH  RYHUHVWLPDWLRQ E\ WKH H0&
DOJRULWKPRIWKHGRVHLQWKHOXQJHTXLYDOHQWPDWHULDOLQFUHDVHVZLWKLQFUHDVLQJGHSWKWKHODUJHVWGLVFUHSDQF\
RI DERXW  RI GRVH DW GPD[ 'PD[ RFFXUULQJ DW WKH GHSWK RI  FP 7KH 0H9 **3% FDOFXODWLRQ
SURGXFHVD3''FXUYHFORVHO\PDWFKLQJWKDWFDOFXODWHGE\WKH0&FRGH)RUWKH0H9EHDPILJXUH
WKH**3%FDOFXODWLRQ SURGXFHV D3''FXUYHZLWK LUUHJXODULWLHV LQ WKH OXQJHTXLYDOHQWPDWHULDO DQG GRVH
YDOXHVDUHORZHUE\DERXWRI'PD[WKURXJKRXWWKH3''FXUYHH[FOXGLQJWKHSKRWRQWDLO7KH0H9
H0&FDOFXODWLRQSURGXFHVD3''FXUYHFORVHO\PDWFKLQJWKDWFDOFXODWHGE\WKH0&FRGH

3.3. Heterogeneous phantom (P3) 
7KHUHVXOWVRIH0&**3%DQG0&FDOFXODWLRQVLQWKH3SKDQWRPDUHVKRZQLQILJXUHIRU0H9DQGLQ
ILJXUH  IRU 0H9 EHDPV 'HSWKV RI SURILOHV LQ WKH &$; SODQH DUH FKRVHQ VR WKDW FXUYHV LQWHUVHFW DW
ORFDWLRQVRI ODUJHVWGLIIHUHQFHVEHWZHHQ UHVXOWV RI H0&DQG**3%FDOFXODWLRQV7KHSURILOHV LQ WKH&$;
SODQHDUHDWGHSWKVRIDQGFPIRU0H9DQGDQGFPIRU0H9EHDPV7KHGHSWKVDUH
VWDWHGZLWKWKHUHVSHFWLYHEROXVWKLFNQHVVHVLQFOXGHG)RUUHVXOWVFRQFHUQLQJWKH3SKDQWRPWKHRXWSXWRI
0&FDOFXODWLRQVVHUYHVDVUHIHUHQFHDVZDVWKHFDVHIRUWKH3SKDQWRP

)RUWKH0H9EHDPILJXUHWKHGRVHSURILOHVFDOFXODWHGZLWKWKHH0&FRGHVKRZVLPLODUVKDSHVDVWKRVH
FDOFXODWHGE\0&EXWLQWKHOXQJHTXLYDOHQWPDWHULDOWKHGRVHYDOXHVFDOFXODWHGE\WKHH0&FRGHDUH
RI'PD[KLJKHUWKDQWKHUHIHUHQFHUHVXOWVRI0&FDOFXODWLRQV,QWKHSURILOHDWVKDOORZHUGHSWKWKHH0&FRGH
UHVXOWVRYHUHVWLPDWHWKHGRVHDOVRRYHUWKHZDWHUHTXLYDOHQWSDUWE\XSWRDERXWRI'PD[,QWKHUHVXOWVRI
WKH**3%FDOFXODWLRQWKHSUHVHQFHRIKHWHURJHQHLW\FRUUHFWLRQOHDGVWRDGRVHGLVWULEXWLRQFORVHUWRWKH0&
UHVXOWVFRPSDUHGWRUHVXOWVREWDLQHGIURPH0&FDOFXODWLRQVRYHUUHJLRQVZKHUHWKHGRVHJUDGLHQWLVVPDOO
LH IXUWKHU DZD\ IURP WKH PDWHULDO ERXQGDU\ ,Q WKH YLFLQLW\ RI WKH PDWHULDO ERXQGDU\ ILJXUH  VRPH
GHYLDWLRQVDUHVHHQLQWKH**3%UHVXOWV RYHUWKHOXQJHTXLYDOHQWUHJLRQWKH**3%FDOFXODWHGGRVHLV
RI'PD[ORZHUWKDQLQWKH0&FDOFXODWHGGRVHSURILOHDQGRYHUWKHZDWHUHTXLYDOHQWUHJLRQLWLVKLJKHU
E\DERXWRI'PD[

FIGURE 4

)RUWKH0H9EHDPUHVXOWVILJXUHWKHGRVHSURILOHVFDOFXODWHGZLWKWKHH0&FRGHDJDLQVKRZVLPLODU
VKDSHVWRWKRVHFDOFXODWHGXVLQJWKH0&FRGHEXWLQWKHOXQJHTXLYDOHQWPDWHULDOWKHH0&FDOFXODWHGGRVHLV
RI'PD[KLJKHU WKDQ WKDW UHVXOWLQJ IURP0&FDOFXODWLRQV7KH**3%FDOFXODWHGSURILOH VKDSHVGLIIHU
IURP WKRVH FDOFXODWHG E\0&DQG H0&FRGHVZLWKPDWFKLQJ GRVH YDOXHV DW FHUWDLQ SRLQWV EXW JHQHUDOO\
HLWKHUXQGHURURYHUHVWLPDWLQJ WKHGRVHDJDLQVW WKH0&UHVXOWVHVSHFLDOO\ LQSURILOHVKRXOGHUVFDOFXODWHG
RYHUUHJLRQVFORVHWRWKHPDWHULDOERXQGDU\ILJXUH,QWKHOXQJHTXLYDOHQWPDWHULDOWKH**3%FDOFXODWHG

3HUIRUPDQFHRIWZRHOHFWURQEHDPDOJRULWKPVLQFKHVWZDOOUDGLRWKHUDS\


GRVH LV ORZHU WKDW FDOFXODWHG E\ WKH0& FRGH E\  RI'PD[ 2YHU WKHZDWHUHTXLYDOHQW SDUW LQ WKH
SURILOHDWODUJHUGHSWKWKLVRYHUHVWLPDWLRQH[FHHGVRI'PD[

FIGURE 5

3.4. Rando-AldersonTM anthropomorphic phantom (P4) 
5HVXOWVRI0&FDOFXODWLRQVSHUIRUPHGIRUWKH0H9EHDPZLWKDQ$DSSOLFDWRUVHUYHGKHUHDVUHIHUHQFH
WRJHWKHU ZLWK UHVXOWV RI LQSKDQWRP 7/' PHDVXUHPHQWV 7KH QXPEHUHG SRVLWLRQV RI 7/'V LQVLGH WKH
DQWKURSRPRUSKLF SKDQWRPDUH VKRZQE\ZKLWH GRWV LQ ILJXUH H )RXU3''FXUYHV FDOFXODWHG XVLQJ WKH
0&H0&DQG**3%FRGHVZHUHH[WUDFWHGIRUFRPSDULVRQ7KH3''GLVWULEXWLRQVZHUHFDOFXODWHGRYHUD[HV
SDUDOOHO WR WKH &$; RIIVHW DORQJ WKH FHQWUDO SODQH RI WKH WKRUD[ VHJPHQW RI WKH 5DQGR$OGHUVRQ70
DQWKURSRPRUSKLF SKDQWRP WR LQWHUVHFW WKH PHDVXUHPHQW SRVLWLRQV RI 7/' GHWHFWRUV ORFDWHG LQVLGH WKH
SKDQWRP7KHFDOFXODWHG3''FXUYHVDQG7/'PHDVXUHGSRLQWGRVHV7/'UHDGRXWVSHUSRLQWWRJHWKHU
ZLWKWKHLUHUURUEDUV6'DUHVKRZQLQILJXUHVDG

,WFDQEHVHHQLQILJXUHVDGWKDWWKH0&FDOFXODWHGGRVHGLVWULEXWLRQJHQHUDOO\FRLQFLGHVZLWKUHVXOWVRI
7/'PHDVXUHPHQWVZLWKLQWKHLUHUURUEDUVDWVHOHFWHGSRLQWVZLWKDIHZH[FHSWLRQVDVVHHQLQILJXUHE
DQGILJXUHF

&RPSDULQJWKHGRVHGLVWULEXWLRQVFDOFXODWHGE\WKHH0&DQG**3%FRGHVDJDLQVWUHIHUHQFH0&FDOFXODWHG
DQG7/'PHDVXUHGGLVWULEXWLRQVZHREVHUYHEHWWHUFRQJUXHQFHRIH0&UHVXOWVWKDQRIWKRVHFDOFXODWHGXVLQJ
WKH**3%DOJRULWKP,QJHQHUDOZLWKLQVWDWLVWLFDOXQFHUWDLQWLHVRIUHVXOWVRIWKHWZR0&EDVHGDOJRULWKPV
WKHH0&FDOFXODWLRQVVOLJKWO\RYHUHVWLPDWHWKHUHIHUHQFH3''VE\QRPRUHWKDQRI'PD[WKHPD[LPXP
RYHUHVWLPDWLRQDWGHSWKRIFPLQILJXUHE,QPDQ\UHJLRQVWKH**3%FDOFXODWLRQXQGHUHVWLPDWHVWKH
UHIHUHQFH3''VHVSHFLDOO\LQWKHOXQJE\XSWRRI'PD[EXWJLYHVPRUHDFFXUDWHUHVXOWVLQWKHWLVVXH
HTXLYDOHQWSDUWRIWKHDQWKURSRPRUSKLFSKDQWRPILJXUHG,QWKHGRVHYROXPHKLVWRJUDP'9+IRUWKH
OXQJLQWKHSKDQWRPDVVXPLQJWKHSUHVFULEHGGRVHRI*\WREH9*\YDOXHVYROXPHIUDFWLRQZLWK
DEVRUEHGGRVHKLJKHUWKDQ*\ZHUHDQGIRUWKH**3%DQGH0&UHVSHFWLYHO\1RWRROVWR
H[WUDFWUHIHUHQFHRUJDQVSHFLILF'9+GDWDIURPWKH0&FDOFXODWLRQVZHUHDYDLODEOH

FIGURE 6

4. Discussion 
,Q WKLV VWXG\ FRPSDULVRQV LQ WKH 3 ZDWHU SKDQWRP VKRZHG WKDW WKH **3% DQG H0& DOJRULWKPV
LPSOHPHQWHG LQ WKH 9DULDQ (FOLSVH 736 SURGXFHG 3'' FXUYHV ZKLFK DJUHHG YHU\ ZHOO ZLWK WKRVH
PHDVXUHGDQGFDOFXODWHGZLWKWKH0&FRGH7KH3SKDQWRPVODEJHRPHWU\ZDVGHVLJQHGWRVWXG\LQPRUH
GHWDLOWKHPDQQHULQZKLFKWKHKHWHURJHQHLW\LVKDQGOHGE\**3%DQGH0&DOJRULWKPV,QWKH3SKDQWRP
JHRPHWU\WKH0&FRGHDQGWKHH0&DOJRULWKPFDOFXODWHGRVHWRPHGLXPOXQJZKLOHWKH**3%DOJRULWKP
FDOFXODWHVGRVHWRZDWHU7KHGLIIHUHQFHLQWKHDEVRUEHGGRVHFDOFXODWLRQEHWZHHQWKHWZRDSSURDFKHVLVWKXV
UHODWHGWRWKHPDQQHULQZKLFKWKHZDWHUWROXQJVWRSSLQJSRZHUUDWLRLVDFFRXQWHGIRU)RUWKLVUHDVRQWKH
**3%FDOFXODWHGGRVHLQ WKH OXQJ LV ORZHU WKHGLIIHUHQFHDW WKHZDWHUOXQJ LQWHUIDFHEHLQJDSSUR[LPDWHO\
RI'PD[7KLVIHDWXUHRIWKH**3%FRGHKDVDOVREHHQUHSRUWHGE\'LQJHWDO >@7KHPRVWSUREDEOH
HQHUJ\RIWKHHOHFWURQVDWWKHGHSWKRIWKHOXQJZDWHULQWHUIDFHziPD\EHDSSUR[LPDWHGE\Ep,0(zi) = Ep,0 (1 - 
zi /Rp)UHVXOWLQJLQDQG0H9IRUWKHQRPLQDOEHDPHQHUJLHVRIDQG0H9UHVSHFWLYHO\>@)RU
WKH0H9HOHFWURQEHDPWKHZDWHUWRPHGLXPVWRSSLQJSRZHUUDWLRLQFUHDVHVIURPWRXQLW\RYHUDVKRUW
UDQJHRIzDVEp,0(z)GHFUHDVHVIURP0H9WR]HURPDNLQJWKHGLIIHUHQFHEHWZHHQGRVHWRPHGLXPDQG
GRVHWRZDWHUYDOXHVQHJOLJLEOH>@)RUWKH0H9EHDPWKHGLIIHUHQFHSHUVLVWVRYHUDEURDGHUUDQJHRIz
LQWKHOXQJ

,QWKHUHVXOWVRIWKH3SKDQWRPFDOFXODWLRQVIRUWKH0H9EHDPRYHUWKHOXQJSDUWILJXUHWKH**3%
DQG 0&FDOFXODWHG 3'' FXUYHV DJUHH ZKLOH WKH H0&FDOFXODWHG 3'' H[FHHGV WKHP WKH GLIIHUHQFH
LQFUHDVLQJ WRZDUGV WKHHQGRI WKH HOHFWURQ UDQJH7KLVPLJKWEH FDXVHGE\ WKHVOLJKWO\GLIIHUHQWYDOXHVRI
VWRSSLQJ SRZHU XVHG LQ WKHVH FDOFXODWLRQV WKRXJK WKH GLIIHUHQFH EHWZHHQ WKH VWDQGDUG OXQJPDVV GHQVLW\

3HUIRUPDQFHRIWZRHOHFWURQEHDPDOJRULWKPVLQFKHVWZDOOUDGLRWKHUDS\


JFPXVHGLQH0&FDOFXODWLRQVDQGWKHPDVVGHQVLW\XVHGLQWKLVVWXG\LVVPDOOE\JFP$
VLPLODURYHUHVWLPDWLRQRIWKHDEVRUEHGGRVHLQWKHOXQJE\WKHH0&DOJRULWKPHVSHFLDOO\DW0H9EXWQRW
IRUDQG0H9EHDPVKDVEHHQUHSRUWHGE\$XEU\HWDO >@ZKHUHDFRQVLGHUDEO\ORZHUYDOXHRI
OXQJPDVVGHQVLW\JFPZDVXVHG)RUWKH0H9EHDPLPPHGLDWHO\DIWHUWKHZDWHUOXQJLQWHUIDFH
WKHGRVHGLIIHUHQFHEHWZHHQ WKH**3%FDOFXODWHG3''FXUYH DQG WKH0&DQGH0&FDOFXODWHG FXUYHV LV
H[SODLQHG E\ WKH GRVHWRZDWHU YV GRVHWRPHGLXP GLIIHUHQFH EHWZHHQ WKH FDOFXODWLRQV EXW WKH UHODWLYH
GLIIHUHQFHEHWZHHQWKRVHUHVXOWVGLPLQLVKHVDVWKHDEVROXWHGRVHGHFUHDVHV:LWKLQFUHDVLQJGHSWKWKHHQHUJ\
RI HOHFWURQV LQ WKHEHDPGLPLQLVKHV DQGFRQVHTXHQWO\ WKH VWRSSLQJSRZHU UDWLR DSSURDFKHVXQLW\7DNLQJ
LQWRDFFRXQWWKHGRVHWRZDWHUYVGRVHWRPHGLXPGLIIHUHQFHWKH**3%FDOFXODWHGFXUYHDJUHHVZLWKWKRVH
FDOFXODWHG E\ H0& DQG0& WRZLWKLQ WKH DERYHHVWLPDWHG XQFHUWDLQW\ H[FHSW IRU WKH XQGHUHVWLPDWLRQ DW
ODUJHUGHSWKV

,QWKHPRUHFOLQLFDOO\UHOHYDQWKDOIVODE3SKDQWRPJHRPHWU\ZKLFKDOVRLQFOXGHGEROXVHVRIDSSURSULDWHO\
FKRVHQ WKLFNQHVVHV WKH GLIIHUHQFHV EHWZHHQ UHVXOWV RI FDOFXODWLRQV DUHPRUH HYLGHQW7KH UHODWLYH GRVH LV
QRWDEO\ KLJKHU LQ WKHPDWHULDO RI ORZHUPDVV GHQVLW\ VLQFHPRUH VFDWWHULQJ RFFXUV LQ WKH DGMDFHQW KLJKHU
PDVVGHQVLW\PDWHULDO7KH³VXUSOXVGRVH´GXHWRODWHUDOVFDWWHULQJFORVHWRWKHZDWHUOXQJLQWHUIDFHLVWKHQ
GHSRVLWHG ZLWKLQ WKH ORZHU PDVV GHQVLW\ PDWHULDO :KHQ FRPSDULQJ WKH UHVXOWV RI H0& DQG **3%
FDOFXODWLRQVRQWKHOXQJHTXLYDOHQWVLGHWKHGRVHGLVWULEXWLRQVIXUWKHUDZD\IURPWKHLQWHUIDFHPDWFKIDLUO\
ZHOOVKRZLQJGLIIHUHQFHVVLPLODUWRWKRVHREVHUYHGLQWKH3RU3SKDQWRPV+RZHYHUFORVHWRWKHOXQJ
ZDWHU LQWHUIDFHDQG WR WKHPLGOLQHRI WKHSKDQWRP WKHGLIIHUHQFHVDUHTXLWHODUJH ,Q WKHUHVXOWVIRUWKH
0H9EHDPWKH**3%DOJRULWKPPDUNHGO\XQGHUHVWLPDWHVWKHGRVHLQWKHOXQJ7KLVHIIHFWLVOHVVYLVLEOHLQ
WKHSURILOHDWODUJHUGHSWK7KHUHDVRQIRUWKLVGLVFUHSDQF\LVGXHWRWKH**3%DOJRULWKPRYHUHVWLPDWLQJWKH
HQHUJ\VFDWWHUHGIURPWKHOXQJWRWKHZDWHUHTXLYDOHQWSDUW,QWXUQWKHGRVHGLVWULEXWLRQFDOFXODWHGE\WKH
**3% DOJRULWKP RQ WKHZDWHUHTXLYDOHQW VLGH DW GHSWKV ODUJHU WKDQ WKH SUDFWLFDO EHDP UDQJH LQZDWHU LV
JURVVO\RYHUHVWLPDWHG7KLVLVDJDLQGXHWRWKHDERYHPHQWLRQHG**3%DVVXPHGODWHUDOVFDWWHULQJIURPWKH
OXQJHTXLYDOHQW VLGH 5HVXOWV RI 3 FDOFXODWLRQV IRU WKH  0H9 EHDP GHPRQVWUDWH VLPLODU IHDWXUHV ZLWK
UHVSHFWWRUHJLRQVRIRYHUDQGXQGHUHVWLPDWLRQLQWKH**3%FDOFXODWHGGHSWKGRVHGHSHQGHQFHVH[FHSWWKDW
WKHGLVWDQFHV WRZKLFK WKHVHGLIIHUHQFHVSHUVLVWDUHDSSUR[LPDWHO\KDOIRI WKRVHVHHQ LQ WKH0H9EHDP
UHVXOWV GXH WR WKH VKRUWHU UDQJH RI ODWHUDO VFDWWHU LQ D 0H9HOHFWURQ EHDP)RU ERWK EHDPHQHUJLHV WKH
OLPLWHG VL]H RI WKH SKDQWRP PD\ UHVXOW LQ LQDFFXUDWHO\ FDOFXODWHG GRVH GLVWULEXWLRQV RYHU WKH SHQXPEUD
UHJLRQEXWWKLVLVQRWFRQVLGHUHGKHUH

)RUWKH0H9EHDPWKHH0&FDOFXODWHGGRVHWRWKHOXQJLQWKH3SKDQWRPLVVOLJKWO\KLJKHUWKDQWKDW
FDOFXODWHGE\WKH0&FRGHZKLOHLQWKHVODEJHRPHWU\3SKDQWRPERWKFRGHVSURGXFHGLGHQWLFDOUHVXOWV
7KLVPD\UHVXOWIURPWKHGLIIHUHQWDSSURDFKHVWDNHQLQWKHWZRFRGHVWRDFFRXQWIRUODUJHDQJOHVFDWWHUIURP
WKH ZDWHUHTXLYDOHQW VLGH 0RVW OLNHO\ E\ WKH VDPH PHFKDQLVP RYHU UHJLRQV IDU IURP WKH LQWHUIDFH WKH
**3%DOJRULWKPFDOFXODWHVKLJKHUGRVHVWRWKHOXQJWKDQGRHVWKH0&FRGH$WWKHOXQJZDWHULQWHUIDFHLQ
WKH3SKDQWRPWKHGRVHYDOXHVFDOFXODWHGE\WKHWKUHHFRGHVDJUHHYHU\ZHOODWERWKEHDPHQHUJLHV

7KHFKRLFHRI0H9HOHFWURQEHDPHQHUJ\WRWUHDWWKH5DQGR$OGHUVRQ70DQWKURSRPRUSKLFSKDQWRPPD\
EHVRPHZKDWH[FHVVLYHRIWKHW\SLFDOHQHUJ\RIVXFKEHDPVXVHGFOLQLFDOO\+RZHYHUWKLVFKRLFHZDVPDGH
IRUHDVLHUFRPSDULVRQZLWKUHVXOWVRIRXUFDOFXODWLRQVLQYLUWXDOSKDQWRPV:HQRWHWKHGLIIHUHQFHLQHOHFWURQ
EHDP DSSOLFDWRUV $ YHUVXV $ LQ WKH YLUWXDO SKDQWRP FDOFXODWLRQV UHVXOWLQJ IURP H[SHULPHQWDO
FRQVLGHUDWLRQV:KHQDQDO\VLQJ7/'UHVXOWVZHQRWHWKDWWKH7/'SHOOHWVRIPPGLDPHWHUDQG[
PPWKLFNQHVVZHUHRULHQWHGZLWK WKHLUD[HVSHUSHQGLFXODU WR WKHEHDPGLUHFWLRQ >@6LQFH WKH7/'UHDG
GRVHYDOXHLVWDNHQWREHPHDVXUHGDWWKHFHQWUDOSRLQWRIWKH7/'DVVHPEO\DQGWKH7/'UHDGRXWRIHDFKRI
WKHWKUHHSHOOHWVLQWKHDVVHPEO\UHSUHVHQWVWKHDEVRUEHGGRVHDYHUDJHGRYHUWKHLUUHVSHFWLYHYROXPHVVRPH
GLVFUHSDQF\PD\EHH[SHFWHG LI WKH7/'SHOOHWDVVHPEOLHVDUHH[SRVHG LQ UHJLRQVRI ODUJHGRVHJUDGLHQWV
7KH7/'PHDVXUHPHQWVLQWKHDQWKURSRPRUSKLFSKDQWRPFRQILUPWKDWGRVHLQWKHOXQJLVXQGHUHVWLPDWHGE\
WKH**3%DOJRULWKPZKLOHWKHGRVHGLVWULEXWLRQVFDOFXODWHGE\H0&DQG0&FRGHVDQGPHDVXUHGE\7/'V
DJUHHYHU\ZHOO7KHXQGHUHVWLPDWLRQRIWKHGRVHGLVWULEXWLRQE\WKH**3%DOJRULWKPRYHUWKHODWHUDOSDUWRI
WKHOXQJVHHQLQILJXUHDLVDOVRTXLWHODUJHGXHWRWKHFORVHQHVVRIWKHODWHUDOHGJHRIWKHOXQJ$VVKRZQ
LQILJXUHEVLPLODUXQGHUHVWLPDWLRQ LVVHHQRYHU WKHPHGLDOSDUWRI WKH OXQJ7KHIXOO0&FDOFXODWLRQ
VKRZVWKHGRVHGLVWULEXWLRQ LQPXFKPRUHGHWDLO LQFOXGLQJPRGLILFDWLRQVE\RWKHUKHWHURJHQHLWLHVVXFKDV
ERQHV7KHFRPPHUFLDODOJRULWKPVGRQRWVKRZVXFKGHWDLOSDUWO\GXHWRWKHODUJHUYR[HOVL]HDSSOLHGLQWKHLU

3HUIRUPDQFHRIWZRHOHFWURQEHDPDOJRULWKPVLQFKHVWZDOOUDGLRWKHUDS\


FDOFXODWLRQV,QWKHPHGLDVWLQXPILJXUHGDOOPHWKRGVRIGRVHFDOFXODWLRQVKRZVLPLODUUHVXOWVH[FHSWIRU
WKH**3%DOJRULWKPZKLFKRYHUHVWLPDWHV WKHGRVHEH\RQG WKHPD[LPXPHOHFWURQ UDQJH$ORQJ WKH7/'
SRVLWLRQVZKLFK OLH YHU\ FORVH WR WKH OXQJPHGLDVWLQXP LQWHUIDFH ILJXUH F WKH**3% FDOFXODWLRQ DOVR
XQGHUHVWLPDWHV WKHGRVHZKLOH DFFRUGLQJ WR UHVXOWV RI3SKDQWRPFDOFXODWLRQV JRRGDJUHHPHQW FRXOGEH
H[SHFWHGDVDOOFDOFXODWLRQVJDYHWKHVDPHUHVXOWVLQWKLVUHJLRQILJXUH7KH**3%DOJRULWKPGLVFUHSDQF\
PD\EHGXH WR WKH VOLJKWGLYHUJHQFHRI WKH HOHFWURQ EHDPDW WKHVHSRLQWV8QGHUHVWLPDWLRQRI WKHGRVHE\
**3%DOJRULWKPUHVXOWHGLQD'9+FDOFXODWHG9*\YDOXHORZHUE\FRPSDUHGWRWKDWREWDLQHGIURP
H0&FDOFXODWLRQV9*\ YHUVXVIRUWKH**3%DQGH0&FDOFXODWLRQVUHVSHFWLYHO\6LQFHWKH
H0&FDOFXODWHG3''FXUYHV LQ WKHSKDQWRPZHUHQHDUO\FRQJUXHQWZLWK WKH0&FDOFXODWLRQWKHREVHUYHG
GLIIHUHQFHV LQ WKH **3% DQG H0&FDOFXODWHG '9+V PD\ EH FOLQLFDOO\ UHOHYDQW GHVSLWH WKH VRPHZKDW
DUWLILFLDOJHRPHWU\RIWKH3SKDQWRP7KHFORVHDJUHHPHQWZLWKLQPHDVXUHPHQWXQFHUWDLQWLHVRIWKH7/'
PHDVXUHPHQWVZLWK UHVXOWV RI0& FDOFXODWLRQV DWWHVWV WR7/'PHDVXUHPHQWV EHLQJ D UHOLDEOHPHWKRG IRU
GRVHPHDVXUHPHQWV LQ WKH OXQJ UHJLRQ RI WKH DQWKURSRPRUSKLF SKDQWRP DW OHDVW DW KLJKHU HOHFWURQ EHDP
HQHUJLHV)RUUHDVRQVGLVFXVVHGHDUOLHURYHUUHJLRQVRIVWHHSGRVHJUDGLHQWVFKDUDFWHULVWLFRIHOHFWURQEHDPV
RI ORZHU HQHUJLHV HYDOXDWLRQ RI DEVRUEHG GRVH DW WKH FHQWUDO SRLQW RI WKH7/' GHWHFWRU DVVHPEO\ SODFHG
LQVLGHWKHDQWKURSRPRUSKLFSKDQWRPPD\EHEXUGHQHGE\DKLJKHUXQFHUWDLQW\

,QJHQHUDORXUUHVXOWVDJUHHZLWKWKRVHRI&ROHPDQHWDO >@ZKRFRPSDUHGGRVHGLVWULEXWLRQVLQWKHOXQJ
FDOFXODWHG E\ WKH SHQFLO EHDP DOJRULWKP DJDLQVW 0& FRPSXWDWLRQV IRU  0H9 HOHFWURQ EHDPV 7KH\
FRQFOXGHGWKDWWKHSHQFLOEHDPFDOFXODWLRQWHQGHGWRXQGHUHVWLPDWHWKHSHQHWUDWLRQRIWKHHOHFWURQEHDPLQ
WKHOXQJDQGWKDWWKHFDOFXODWHGGRVHWRWKHOXQJDQGWKHKHDUWZDVXQGHUHVWLPDWHG'LQJHWDO>@FRPSDUHG
H0&FDOFXODWHGGRVHGLVWULEXWLRQVIURPDQG0H9HOHFWURQEHDPVWRPHDVXUHPHQWVLQZDWHUDQGDURXQG
DFPWKLFNVODERIOXQJSODFHGDWFPGHSWKDQGH[WHQGLQJIURPWKH&$;RXWZDUGV7KHLUUHVXOWVVKRZHG
WKHGRVHWRZDWHUYVGRVHWROXQJGLIIHUHQFHPRUHFOHDUO\EHFDXVH WKHFRPSDULVRQZDVPDGHDWD VKDOORZ
GHSWKZKHUHWKHHQHUJ\LVKLJKHUDQGWKHZDWHUOXQJVWRSSLQJSRZHUUDWLRIXUWKHUGHYLDWHVIURPXQLW\7KH\
DOVR VKRZHG WKDW WKH PRGLILFDWLRQ RI WKH GRVH GLVWULEXWLRQ EHORZ WKH OXQJ VODE GXH WR LWV SUHVHQFH LV
DFFXUDWHO\FDOFXODWHGE\WKHH0&DOJRULWKP+RZHYHUWKHWHVWDUUDQJHPHQWZKHUHWKHOXQJVODELVFORVHWR
WKHVXUIDFHGRHVQRWUHSUHVHQWWKHOXQJPHGLDVWLQXPLQWHUIDFH)RUWKHDQWKURSRPRUSKLFJHRPHWU\$XEU\HW
DO>@UHSRUWHGWKHODUJHVWGLVFUHSDQF\EHWZHHQH0&FDOFXODWLRQVDQGILOPPHDVXUHPHQWVRFFXUULQJDWWKH
OXQJPHGLDVWLQXPLQWHUIDFHEH\RQGWKHGHSWKRIHOHFWURQUDQJHLQZDWHU7KLVGLVFUHSDQF\ZDVODUJHVWIRU
0H9HOHFWURQEHDPV$VVHHQLQILJXUHRXUUHVXOWVVXSSRUWWKHVHFRQFOXVLRQV+RZHYHUWKHQRUPDOL]DWLRQ
SURFHGXUHXVHGE\$XEU\HWDO>@GRHVQRWQHFHVVDULO\JLYHWKHDEVROXWHGLIIHUHQFHDFFXUDWHO\HQRXJK

7KH FOLQLFDO LPSOLFDWLRQV RI WKH REVHUYHG GLVFUHSDQFLHV EHWZHHQ GRVH GLVWULEXWLRQV FDOFXODWHG E\ GLIIHUHQW
DOJRULWKPVDUHUHOHYDQWPDLQO\WRFKHVWZDOOLUUDGLDWLRQDVVRFLDWHGHJZLWKSRVWPDVWHFWRP\EUHDVWFDQFHU
UDGLRWKHUDS\ZKHUHWKHFKHVWZDOOWKLFNQHVVLVW\SLFDOO\ORZHUVRHOHFWURQEHDPVRIORZHUHQHUJLHVQHHGWR
EHXVHGRUWRERRVWHOHFWURQWKHUDS\ZKHUHWKHWKLFNQHVVRIWKHEUHDVWWLVVXHLVW\SLFDOO\ODUJHUDQGSDUWRI
WKH FKHVW ZDOO LV LQFOXGHG LQ WKH 379 UHTXLULQJ WKH XVH RI HOHFWURQ EHDPV RI KLJKHU HQHUJLHV ,Q WKHVH
WHFKQLTXHVWKHDQWHULRUHOHFWURQILHOGPD\H[WHQGRYHUWKHPHGLDVWLQXPDQGWKHOXQJPHGLDVWLQXPLQWHUIDFH
LV RYHU VRPH GHSWKV FORVH WR EHLQJ SDUDOOHO WR WKH GLUHFWLRQ RI WKH EHDP7KH RXWFRPH LV WKDW WKH**3%
DOJRULWKPZLOOXQGHUHVWLPDWHWKHGRVHWRWKHOXQJFORVHWRWKHPHGLDVWLQXPZKLFKPD\KDYHDVOLJKWHIIHFW
RQ WKH FDOFXODWHG '9+ E\ ORZHULQJ WKH DYHUDJH GRVH 8QGHUHVWLPDWLRQ RI GRVH WR WKH OXQJ LQ RXU VODE
JHRPHWU\DWKLJKHUHOHFWURQEHDPHQHUJLHVZRXOGKDYHDVLPLODUHIIHFW$WWKHKLJKHOHFWURQEHDPHQHUJ\RI
0H9WKLVHIIHFWRIXQGHUHVWLPDWLRQLVTXLWHHYLGHQWEXWLWPD\DOVREHVHHQDWWKHORZHUHOHFWURQEHDP
HQHUJ\0H9\HWFRQILQHGWRDVKRUWHUUDQJHDQGVPDOOHUYROXPHLQWKHOXQJ8QGHUHVWLPDWLRQRIWKHGRVH
LQWKHOXQJE\WKH**3%DOJRULWKPZRXOGLPSO\WKDWLIVLPLODU'9+FRQVWUDLQWVHJIRU9*\ZHUHDSSOLHG
LQSODQQLQJZLWKERWKDOJRULWKPVWKHGRVHGHOLYHUHGWRWKHOXQJZRXOGEHKLJKHULIWKH**3%DOJRULWKPLV
DSSOLHG7KHGRVHYHU\FORVHWRWKHOXQJPHGLDVWLQXPLQWHUIDFHZKHUHHJWKHFRURQDU\DUWHULHVDUHORFDWHG
ZRXOG EH IDLUO\ FRUUHFWO\ HVWLPDWHG E\ HLWKHU DOJRULWKP:LWK UHVSHFW WR WKH GRVH WR WKHP\RFDUGLXP WKH
**3%DOJRULWKPFOHDUO\RYHUHVWLPDWHV LW DV VKRZQ LQ ILJXUHV DQG7KHH0&DOJRULWKPFDOFXODWHV WKH
GRVHFORVHWRWKHLQWHUIDFHZLWKEHWWHUDFFXUDF\HVSHFLDOO\RYHUWKHZDWHUHTXLYDOHQWVLGHEXWJLYHVVOLJKWO\
KLJKHUGRVHYDOXHVLQWKHOXQJE\VRPHFRPSDUHGWRWKHUHIHUHQFH0&FDOFXODWLRQV
5. Conclusions 

3HUIRUPDQFHRIWZRHOHFWURQEHDPDOJRULWKPVLQFKHVWZDOOUDGLRWKHUDS\

7KHGRVHGLVWULEXWLRQVFDOFXODWHGE\WKHH0&FRGHLQWKHSKDQWRPJHRPHWULHVXVHGLQWKLVVWXG\ZHUHFORVH
WR WKRVH UHVXOWLQJ IURP 0& FDOFXODWLRQV WKH H0& FRGH VOLJKWO\ RYHUHVWLPDWLQJ WKH GRVH LQ WKH OXQJ
HTXLYDOHQWWLVVXH,QFKHVWZDOOHOHFWURQEHDPWKHUDS\WKHNQRZQGLIIHUHQFHVLQWKHKHWHURJHQHLW\DQGODWHUDO
VFDWWHULQJFDOFXODWLRQVSUHVHQWLQWKH**3%FRGHPD\OHDGWRVLJQLILFDQWXQGHUHVWLPDWLRQRIWKHDFWXDOGRVH
GHOLYHUHGWRWKHOXQJDQGWRRYHUHVWLPDWLRQRIWKHGRVHWRWKHPHGLDVWLQXPDWFHUWDLQGHSWKV7KLVPD\DIIHFW
WKHRSWLPL]DWLRQRIVXFKSODQVLQWHUPVRI'9+VRYHUYROXPHVFORVHWRWKHOXQJPHGLDVWLQXPLQWHUIDFHVXFK
DV WKH P\RFDUGLXP RU FRURQDU\ DUWHULHV *RRG DJUHHPHQW EHWZHHQ 7/' PHDVXUHPHQWV DQG %($0QUF
FDOFXODWLRQV LQ WKH DQWKURSRPRUSKLF SKDQWRP DWWHVWV WR WKH DFFXUDF\ RI WKLV ³IXOO´ 0& FRGH DQG LWV
DSSOLFDELOLW\DVDUHIHUHQFHIRUEHQFKPDUNLQJFRGHVXVHGLQFRPPHUFLDOUDGLRWKHUDS\SODQQLQJV\VWHPV

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